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CHAPTER I 
 
INTRODUCTION 
 
I. Lipid Signaling in Reproduction 
Although the human population is growing rapidly, 15% of couples worldwide are 
infertile (1, 2), with infertility defined as the inability to conceive after one year of 
regular sexual intercourse. Infertility is a worldwide social and economic concern. 
Early pregnancy loss in humans often happens due to defects that occur before, 
during or immediately after implantation. In addition, the implantation rate 
remains disappointingly low in in vitro fertilization and embryo-transfer (IVF-ET) 
techniques which have overcome several causes of human infertility. Therefore, 
studying the physiological, genetic and molecular basis of implantation is 
important. However, it is difficult to define the hierarchical landscape of molecular 
pathways during human pregnancy because of experimental difficulties and 
ethical restrictions on research with human embryos. It is hoped that experiments 
on mice and other animal models combined with feasible experiments in humans 
will generate meaningful information to address these critical issues. Although 
details of many of the molecular interactions during the periimplantation events 
have not yet been defined, increasing evidence from gene expression and 
transgenic mouse studies reveal that synchronous development of 
preimplantation embryos to the blastocyst stage and differentiation of the uterus 
to the receptive stage are prerequisites for the initiation of implantation (3-5). 
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 Over the past several years, molecular and genetic studies have provided 
evidence that lipid mediators, including prostaglandins (PGs) and 
lysophospholipids, are critical signaling molecules in coordinating events of early 
pregnancy (6-9). PGs, a major group of eicosanoid lipid mediators, are generated 
from arachidonic acid (AA), which is released from membrane phospholipids by 
phospholipase A2 (PLA2). AA thus released is transformed by cyclooxygenases 
(COXs) to PGH, which is then converted to various PGs by specific PG 
synthases (10). In mice, PGF2α is mainly generated by COX-1 as a luteolytic 
hormone acting on the corpus luteum, which is critical for the onset of parturition 
(15–18), whereas PGI2 and PGE2 generated by COX-2 are essential for ovulation, 
fertilization, implantation, and decidualization (11, 13, 19–22). The role of PGs 
during pregnancy is further illustrated by poor fertility, resulting from deferred 
implantation, in mice lacking cPLA2α (12). Lysophosphatidic acid (Lyso-PA) 
belongs to another group of lipid mediators, lysophospholipids. Lyso-PA 
influences a range of biological processes through its cell surface G protein-
coupled receptors, LPA1–4 (32). Mice missing LPA3, a G protein-coupled receptor 
of Lyso-PA, exhibit defects remarkably similar to defects in cPLA2α-deficient mice, 
such as deferred on-time implantation, retarded fetal development, embryo 
crowding, and sharing of one placenta by several embryos (12, 33). More 
intriguingly, the on-time implantation in LPA3 deficient females is restored by PG 
supplementation (33). These studies suggest that appropriate lipid signaling is 
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indispensable for periimplantation events and that there is a cross-talk interaction 
between different lipid signaling pathways. 
 
Recently, endocannabinoid signaling, mediated by another group of bioactive 
lipid molecules, has been highlighted as an important player in male and female 
reproductive systems. During the past 15  years, research from our laboratory 
demonstrated that the endocannabinoid system is present in the preimplantation 
embryo, oviduct and uterus, and revealed that appropriate endocannabinoid 
signaling is critical to preimplantation embryo development, their timely homing 
into the receptive uterus and on-time implantation (10-12). My work has added a 
new dimension to these studies in both male and female reproduction. The 
following chapters will illustrate these new findings.  
 
II The Endocannabinoid System 
 
Introduction 
Marijuana, derived from the plant Cannabis sativa, has been used as a 
recreational drug for thousands of years due to its psychoactive effects including 
euphoria, sedation and analgesia.  Because of its widespread use, research on 
the chemistry of Cannabis began decades ago (13). However, its major active 
component, Δ9-tetrahydrocannabinol (Δ9-THC), was not identified until 1964 (14).  
This discovery initiated a dramatic interest in cannabinoid research, further 
increased by the discovery and cloning of two types of cannabinoid receptors, 
 3
brain-type (CNR1) (15, 16) and spleen-type (CNR2) (17). Around the same time, 
several endogenous compounds targeting CNR1 and CNR2 were identified; they 
are collectively termed endocannabinoids. The two most studied 
endocannabinoids are anandamide (AEA) and 2-arachidonoylglycerol (2-AG). 
The structure of anandamide was first revealed in 1992 (18), while 2-AG was 
discovered in both the canine gut (19) and the rat brain (20) by two independent 
groups. All of the endocannabinoids, the enzymes responsible for their 
biosynthesis and degradation, and their receptors are collectively called the 
endocannabinoid system (Figure 1). Various aspects of the endocannabinoid 
system are described below. 
 
AEA synthesis and degradation 
It is widely accepted that anandamide is derived from the precursor N-
arachidonoylphosphatidylethanolamine (NAPE) through its reaction with NAPE-
hydrolyzing phospholipase D (NAPE-PLD) (21, 22), a member of the metallo-
lactamase family with Ca2+ sensitive enzyme activity (23, 24). However, 
unaltered polyunsaturated NAE (N-acyl-ethanolamine) levels in NAPE-PLD 
deficient mice suggests other anandamide synthetic pathways (25). Recently, 
two other enzymatic routes were identified: 1) double deacylation of NAPE by a 
phospholipase/lysophospholipase B, α/β-hydrolase 4 (Abh4), to generate 
glycerophospho-NAE (GP-NAE) which is then cleaved by a phosphodiesterase 
to liberate anandamide (26), and 2) cleavage of NAPE by a phospholipase C to 
generate phosphoanandamide (pAEA), which is subsequently dephosphorylated 
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by a protein tyrosine phosphatase, PTPN22, to release anandamide (27).  
Although these pathways are found in both the CNS and peripheral tissues, the 
mechanisms by which these pathways can regulate and affect each other are still 
unknown. 
 
 
FIGURE 1. The endocannabinoid system. The synthesis of AEA from 
membrane N-arachidonoylphosphatidylethanolamines is catalyzed by the 
sequential activity of NAT and NAPE-PLD, which releases AEA and phosphatidic 
acid. AEA is transported in both directions through the cell membrane by a 
selective AMT and, once taken up, is hydrolyzed by FAAH to ethanolamine 
(EtNH2) and AA. The main targets of AEA are CNR1 and CNR2 receptors (CBR), 
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showing an extracellular binding site, and type-1 vanilloid receptors (TRPV1), 
showing an intracellular binding site. 2-AG is also released from membrane lipids 
through the activity of DAGL. 2-AG can also be hydrolyzed by FAAH or, more 
importantly, by MAGL, releasing glycerol and AA. The transport of 2-AG across 
the cell membrane may be mediated by AMT or a related transporter, and CBR 
(but not TRPV1) is the target of this endocannabinoid. The picture is adapted 
from Wang et al, Endo Rev, 27: 427-448, 2006. 
 
 
Anandamide is degraded to ethanolamine and arachidonic acid (AA) by a 
membrane-bound fatty acid amide hydrolase (FAAH) (28, 29). FAAH can also 
hydrolyze other fatty acid amides, including 2-AG and the sleep-inducing 
substance oleamide (30). FAAH has been shown to be critical for regulating both 
the magnitude and duration of anandamide and other fatty acid amide signaling 
(31). Recently, a second membrane-associated fatty acid amide hydrolase has 
been  found in humans and other primate genomes but not in that of the rodent 
(32).  
 
The transport mechanism of anandamide, an uncharged hydrophobic molecule, 
across the plasma membrane is still under debate (33, 34). In the current models, 
the enzymes for the synthesis and degradation of endocannabinoids are thought 
to be located within the cell, so that the stimulation of cannabinoid receptors by 
endocannabinoids from the extracellular component requires these lipid 
mediators to cross the plasma membrane twice. While pharmacological and 
biochemical evidence points towards the existence of a specific anandamide 
transport protein using transporter inhibitors (35-38), no direct evidence for such 
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a transporter has been provided.  Recently developed drugs have been shown to 
inhibit anandamide transport without affecting FAAH activity (39). However, 
chemical evidence shows that anandamide uptake is not reduced by putative 
transport inhibitors in FAAH knock-out cells, favoring the model that anandamide 
traverses the cell plasma membrane by simple diffusion (40). In addition, FAAH 
may not need a transporter to help reach its substrate anandamide (41). 
 
2-AG synthesis and degradation 
2-AG is derived from the precursor diacylglycerol by a membrane-bound sn1-
diacylglycerol lipase (DAGL (42). To date, two isoforms of DAGL have been 
cloned, DAGLα and DAGLβ. The former is found mostly in the adult brain, while 
the latter is expressed in the developing brain (43). Like anandamide, 2-AG is 
produced on demand, but they differ in that anandamide often acts only as a 
partial agonist of cannabinoid receptors, while 2-AG acts as a full agonist.  
Interestingly, 2-AG’s binding affinity to cannabinoid receptors is approximately 24 
times less than that of anandamide but under most physiological conditions, 2-
AG levels are much higher than anandamide (44). It still remains to be 
determined, therefore, how only a small percentage of 2-AG (10-20%) crosses 
the plasma membrane to interact with cannabinoid receptors (45).   
 
2-AG accumulated in cells is degraded by either FAAH or a serine hydrolase, 
monoacylglycerol lipase (MAGL) (46). MAGL, a 33-KD protein, has been isolated, 
cloned and characterized in both rats and humans (46-48). Unlike FAAH, MAGL 
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is localized primarily in the cytosol, but not on the plasma membrane. Recently, 
using BV-2 cells, a mouse microglial cell line with MAGL activity, Muccioli et al. 
identified a novel protein which regulates 2-AG levels (49). 
 
Cannabinoid receptors 
Endocannabinoids, as well as plant-derived and synthetic cannabinoids, target 
cannabinoid receptors CNR1 and CNR2. Both CNR1 and CNR2 are G protein-
coupled receptors with seven transmembrane domains. CNR1 is present mostly 
in the central nervous system and in some peripheral tissues including the heart, 
testis, liver, small intestine and uterus, while CNR2 is abundantly expressed in 
the spleen and several immune cells, including astrocytes (50-52). Both CNR1 
and CNR2 are coupled with G proteins in the Gi/o and Gq families, and the 
activation of cannabinoid receptors has different biological effects that are cell-
type dependent. Signals mediated by cannabinoid receptors include regulation of 
Ca2+ channels (53-57), inhibition of adenylyl cyclase (16, 58), activation of 
phopholipase C (59) and stimulation of mitogen-activated protein kinases 
(MAPKs) including ERK, JNK and p38 (56, 60, 61). 
 
In addition to CNR1 and CNR2, some evidence indicates the existence of other 
putative cannabinoid receptors (62). For example, it was shown that anandamide 
can protect murine neuroblastoma cells subjected to low serum-induced 
apoptosis by non-CNR1, non-CNR2 receptors (63). Furthermore, a novel 
cannabinoid receptor 3 (GPR55) has been reported (64, 65), which as of yet, is a 
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G protein-coupled orphan receptor. The physiological role of this receptor is not 
clearly understood.  
 
Anandamide, but not 2-AG, can also activate receptors other than CNR1 and 
CNR2. One receptor that anandamide activates is the transient receptor potential 
vanilloid 1 (TRPV1) (66), a ligand-gated non-selective cationic channel. The 
binding of anandamide to its cytosolic binding site on TRPV1 triggers Ca2+ influx 
and eventual cytochrome c release (67, 68). 
 
III. Endocannabinoids and Male Fertility 
 
Introduction 
The role of the endocannabinoid system in male fertility remains largely 
unexplored. Previous studies showed that rat testes are able to synthesize AEA 
(69), and there is evidence that long term exposure to THC induces male 
infertility (70). In addition, AEA is also present in human seminal plasma at 
nanomolar ranges (71), and human sperm fertility is influenced by AEA (72). 
Furthermore, components of the endocannabinoid system are detected in 
different cell types in the testis. CNR1 is present in leydig cells (73), which secret 
the main male hormone testosterone, whereas CNR2 is present in sertoli cells, 
which support spermatogenesis (74). Although some evidence indicates that 
testosterone secretion and sertoli cell function are both associated with AEA 
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levels in the testis, the underlying molecular mechanism of the association is still 
not known.   
  
The endocannabinoid system in Sertoli cells 
Sertoli cells are located within the seminiferous tubes. Before being released into 
the seminiferous tubes, sperm in different developmental stages have direct 
contact with sertoli cells, which regulate spermatogenesis by providing nutrients 
and hormonal signals. In mice, the expression of CNR2 on sertoli cells is 
consistent throughout the lifespan (74). However, the FAAH activity declines with 
age.  Previous studies showed that sertoli cells undergo apoptosis after being 
exposed to AEA (74), and that this effect is mediated by receptors other than 
CNR1, CNR2 and TRPV1. In fact, CNR2 located on sertoli cells can protect the 
cells from apoptosis. FAAH is regulated by FSH, a hormone critical for fetal and 
early neonatal sertoli cell proliferation and for regulating spermatogenesis in adult 
males (75). Additionally, FAAH can modulate the pro-apoptotic effect of AEA on 
sertoli cells (74) indicating a close interplay between endocannabinoid signaling 
and hormones. Collectively, these results indicate that the endocannabinoid 
system is a new potential target to treat male infertility.  
 
The endocannabinoid system in sperm 
Endocannabinoid signaling has been shown to regulate sperm function in both 
invertebrates and mammals (72, 76-79). In sea urchins, sperm synthesize AEA 
(80) and AEA binds to CB receptors (77). Type-1 cannabinoid receptors and 
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FAAH are also found in the frog and rat (81). The endocannabinoid system in 
boars has been characterized by Dr. Maccarrone’s group. Boar spermatozoa 
have the biochemical machinery to synthesize (NAPE-PLD), and degrade (AMT 
and FAAH) AEA (82). In addition, the targets of AEA, CNR1 and TRPV1 are 
present in boar spermatozoa. Only a limited number of studies have focused on 
understanding the role of the endocannabinoid system in sperm function using 
mouse models. There is evidence that CNR1 and FAAH are present in mouse 
spermatozoa (81). Another study shows that the biosynthetic and degrading 
enzymes of 2-AG, and CNR2 receptors are present in spermatogonia to 
spermatozoa during spermatogenesis in mice (83).  
 
In mammals, ejaculated sperm must undergo a functional maturation, named 
“capacitation”, to acquire the competence to fertilize an egg. During this 
biological process, intracellular calcium signaling is elevated and hyperactivated 
sperm motility is facilitated. These events are accompanied by changes in protein 
components on sperm heads that induce the acrosome reaction, enabling sperm 
to bind to the zona pellucida (ZP). Although previous studies show that this 
process involves modifications of intracellular ions (84, 85),  plasma membrane 
fluidity (86), metabolism, and motility (87), the molecular signaling pathways and 
the local regulatory mechanism that allows capacitation to progress remain 
poorly understood. Recent evidence suggests that endocannabinoid signaling is 
involved in spermatogenesis and capacitation. In mouse spermatogenesis, while 
2-AG likely plays an important role in promoting the meiotic progression of germ 
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cells by activating CNR2 receptors (83), endocannabinoid signaling through 
CNR1 helps keep sperm quiescent in the epididymis. A previous report showed 
that the percentage of motile sperm retrieved from the caput is lower than the 
sperm from the cauda, but the percentage of motile sperm within the caput is 
increased in the absence of CNR1 (88). Endocannabinoid signaling is also 
involved in sperm capacitation. In boars activation of CNR1 by an AEA-stable 
analog methanandamide (mAEA), inhibits capacitation (and hence the ability of 
sperm cells to react to ZP (zona pellucida) proteins with acrosome exocytosis) 
through a cAMP-dependent pathway, although CNR1 had no effect on 
spontaneous acrosome reaction (82). It was also noted that once the 
capacitation is completed, AEA stabilizes the acrosome membranes by activating 
TRPV1, thus reducing spontaneous acrosome reaction. In addition, AEA has 
been shown to reduce human sperm motility and capacitation-induced acrosome 
reaction (89). The effects can be blocked by a CNR1 antagonist SR141716, 
suggesting that the activity of AEA on sperm function requires CNR1 activation 
(89). 
 
IV. Endocannabinoids and Female Reproduction 
 
Periimplantation events 
The beginning of a new life starts with the fertilization of an egg by a sperm (90, 
91). The fertilized egg, now termed an embryo, develops inside the oviduct 
undergoing several mitotic divisions leading to a compacted ball of cells termed a 
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morula (Figure 2).  The morula travels towards the uterus and, at the same time, 
a small cavity appears marking the beginning of the blastocyst stage. A 
blastocyst consists of two cell populations, the inner cell mass (ICM) which forms 
the embryo proper, and the outer layer of trophectoderm cells which generates 
the placenta and extraembryonic membranes (5, 92-94).  
 
It is only at the blastocyst stage that an embryo makes its first physical and 
physiological contact with the uterine endometrium to begin the process of 
implantation (Figure 2). A reciprocal interaction between the blastocyst and 
receptive uterus is essential for successful implantation. For instance, the uterus 
can only accept the blastocyst for attachment when it is in the receptive state.  It 
is only then that the uterus is able to support blastocyst growth, attachment, and 
subsequent implantation (3, 5, 95, 96). Although the genetic and molecular basis 
for implantation is not yet clearly understood, gene expression studies and 
genetically engineered mouse models have shown that various signaling 
pathways are involved in the implantation process with endocannabinoid 
signaling being a key player (3-5, 97). 
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 FIGURE 2.  Preimplantation embryo development and implantation in mice. 
Following fertilization in the oviduct, the embryo undergoes several rounds of 
mitotic cell division, ultimately forming a ball of cells called a morula. At the late 
morula stage, the embryo enters the uterine lumen and transforms into a 
blastocyst that contains a cavity (called a blastocoel) with two distinct cell 
populations, the inner cell mass (ICM) and the trophectoderm (the progenitor of 
trophoblast cells). Before implantation, the blastocyst escapes from its outer shell 
(the zona pellucida) and differentiates to produce additional cell types — the 
epiblast and the primitive endoderm. At this stage, the trophectoderm attaches to 
the uterine lining to initiate the process of implantation. E, embryonic day. 
 
 
Endocannabinoid signaling in the mouse female reproductive system 
Both CNR1 and CNR2 receptors are expressed in the female mouse 
reproductive system. In preimplantation embryos, CNR1 is expressed from the 
late 2-cell through the blastocyst stage, whereas CNR2 is present from the 1-cell 
stage. CNR1 is localized primarily in the mural trophectoderm and intermittently 
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in the polar trophectoderm, but not in the inner cell mass (58). However, CNR1, 
but not CNR2, is also found in both the oviduct and uterus (12, 98).  
 
Not only are the receptors present in these tissues, but also the enzymes 
necessary for the synthesis and degradation of anandamide.  For example, 
NAPE-PLD is present in the nucleus and cytoplasm of preimplantation embryos 
from the 1-cell stage to the blastocyst stage and FAAH is present from the 2-cell 
stage to the blastocyst stage. Notably, FAAH is uniquely found in outer cell layers 
of morulae and in the trophectoderm of blastocysts. In the oviduct, NAPE-PLD 
levels are higher in the isthmus compared to levels in the ampullary region, 
whereas FAAH shows the reverse pattern, being higher in the ampullary region 
(11, 99). This inverse relationship holds true for FAAH and NAPE-PLD following 
implantation, in that NAPE-PLD levels are higher in inter-implantation sites on 
days 5 and 7 (day 1 = presence of vaginal plug) where FAAH levels are low, and 
NAPE-PLD levels are lower in implantation sites where FAAH levels are higher 
(100).  
 
With respect to 2-AG synthesis, the dominant DAGL isoform, DAGLα, is almost 
undetectable on days 1 and 4 of pregnancy, but is markedly upregulated in the 
luminal epithelium of inter-implantation sites on days 5 and 7. MAGL is present at 
low levels in both the luminal and glandular epithelia on days 1 through 4 of 
pregnancy. On days 5 through 7, MAGL expression is induced in subepithelial 
stromal cells at the site of blastocyst attachment and in the embryo, whereas at 
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the interimplantation sites its lower level of expression is restricted to the luminal 
and glandular epithelia (100). 
  
The tightly regulated spatiotemporal expression patterns of the key synthetic and 
hydrolytic enzymes and cannabinoid receptors create appropriate 
endocannabinoid signaling conducive to successful early pregnancy events, 
including preimplantation embryo development and on-time implantation.  
 
Endocannabinoid signaling and preimplantation embryo development 
Development of preimplantation embryos to blastocysts is critical for achieving 
implantation competency. Delayed development leads to defective implantation 
or implantation failure and, consequently, compromised pregnancy (5). Embryos 
exposed to high levels of endocannabinoids, as well as to plant-derived and 
synthetic cannabinoids, show retarded development. For example, high levels of 
anandamide causes blastocysts to have a reduced number of trophectoderm 
cells and decreases the rate of zona-hatching (101, 102). It has also been shown 
that anandamide, 2-AG, THC and WIN55212-2 (a synthetic cannabinoid agonist) 
arrest development of two-cell embryos to blastocysts (Figure 3) (58, 103).  This 
arrested development, however, can be rescued by SR141716A and AM251 
(CNR1 selective antagonists), but not by SR144528 (a CNR2 specific antagonist). 
Furthermore, a CNR2 agonist, AM663, fails to affect embryo development (103). 
These studies collectively indicate that endocannabinoids and cannabinoids 
mediate their effects on preimplantation embryos through CNR1.   
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 The availability of Cnr1-/- and Cnr2-/- mouse models greatly expanded the field of 
endocannabinoid research.  Using these mice, it was observed that Cnr1-/- and 
Cnr1-/- Cnr2-/- embryos recovered from oviducts on day 3 and from uteri on day 4 
of pregnancy show aberrant development compared with wild-type embryos 
(104).  
 
FIGURE 3. Cannabinoid signaling in preimplantation embryo development. 
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At a higher level of anandamide (28nm), cannabinoid signaling mediated by 
CNR1 inhibits trophectoderm proliferation and preimplantation embryo 
development. Blockage of endocannabinoid signaling also causes retarded 
preimplantation embryo development. 
 
Interestingly, heterozygous embryos recovered from Cnr1-/- females mated with 
wild-type males showed normal embryo development (12). This finding prompted 
the hypothesis that while high cannabinoid levels can arrest early embryonic 
development, appropriate cannabinoid signaling under normal physiological 
conditions is beneficial to normal embryo development. This idea was then 
confirmed by in vitro embryo culture experiments, showing that low levels of 
anandamide (7 nM) promoted trophoblast differentiation and growth, while higher 
levels (28 nM) inhibited such development (105). The normal development of 
heterozygous embryos in a Cnr1 deficient environment indicated that embryonic 
Cnr1 receptors, but not oviductal Cnr1 receptors, directed proper early embryonic 
development (10). It has been shown previously that most (79%) 2-cell wild-type 
embryos fail to develop to the blastocyst stage in the presence of excess 
anandamide. In contrast, more than 80% of Cnr1-/- or Cnr1-/-Cnr2-/- double mutant 
embryos develop into blastocysts in the presence of similar levels of anandamide. 
However, in vitro development of Cnr2-/- embryos, like wild-type embryos, was 
severely compromised in the presence of anandamide (104). These results lend 
genetic support to the previous conclusion that CNR1, but not CNR2, respond to 
cannabinoids to govern embryonic development.  
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Interestingly, Cnr2-/- embryos collected from the oviduct on day 3 and uterus on 
day 4 also show some aberrant development (104), indicating that CNR2 does 
play some role in preimplantation embryo development. Recent observations of 
CNR2 expression in embryonic stem cells identified by microarray analysis (106) 
together with its absence in trophoblast stem cells (107), suggest that CNR2 
expression is restricted to the inner cell mass of blastocysts. Thus, it is 
conceivable that CNR2 may play a role in ICM cell development and therefore, 
development of the embryo proper.  
 
Collectively, cannabinoid signaling regulates preimplantation embryo 
development, with the current model implicating its mediation by the CNR1 
receptor. Although the role of CNR2 remains puzzling, it seems to function as a 
low level cannabinoid signaling gatekeeper for preimplantation embryo 
development. 
 
Endocannabinoid signaling and oviductal-uterine embryo transport 
In parallel with preimplantation development, embryos are transported from the 
oviduct into the uterus. Embryos enter the uterus at the late morula stage and, 
coincident with this transport, a cavity appears marking the early blastocyst stage. 
The embryo only achieves implantation competency at the blastocyst stage. 
Thus, a successful implantation depends on the normal and timely transport of 
embryos from the oviduct into the uterus (Figure 4a). Although there is no 
evidence for implantation of embryos in the mouse oviduct, embryos can implant 
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in the human oviduct (Fallopian tube). Thus, a dysfunctional regulation of 
oviductal-uterine transport results in oviductal retention of embryos and can 
cause ectopic pregnancy in women (108, 109). 
 
 
FIGURE 4. a. Murine oviduct transport of preimplantation embryo. An egg is 
fertilized in the ampula of the oviduct. Through cell division, it becomes a 2-cell, 
4-cell, and 8-cell embryo, and eventually forms a morula. The morula passes 
through the utero-tubal junction to enter the uterus. b. Schematic picture of 
cross section of the oviduct. Ep, epithelium. c. Muscularis movement of 
utero-tubal junction at different concentrations of AEA. In the absence of 
AEA, NE causes muscle constriction, resulting in a narrow lumen. In the higher 
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concentration of AEA, cannabinoid signaling through CNR1 reduces the 
secretion of NE, thus relaxing muscle cells, resulting in a bigger lumen. The 
appropriate concentration of AEA triggers the muscle relaxation bit by bit to make 
a wave of the lumen, which is conducive for the embryo to enter uterus. Part a. is 
adapted from “Manipulating the Mouse Embryo; A Laboratory Manual”, page 497, 
1994, Hogan, B et al. 
 
Studies have shown that Cnr1+/- embryos have normal preimplantation 
development in Cnr1-/- oviducts. Interestingly, about 40% of the Cnr1-/- mothers 
still show pregnancy loss (12, 104). The observation that some Cnr1-/- females, 
mated with wild type males, did not have embryos in the uterus when flushed on 
the morning of day 4 of pregnancy suggested oviductal retention of embryos. 
Cnr1-/-/Cnr2-/- mice also show oviductal retention, but wild-type and Cnr2-/- mice 
do not, suggesting oviductal retention results specifically from the absence of 
Cnr1. This can be explained by the expression of Cnr1 in the mouse oviduct.  
This same study showed that all of the oviduct-trapped embryos were 
morphologically and physiologically healthy, because they were able to implant in 
day 4 pseudopregnant uteri upon transfer, suggesting again that oviductal 
retention is due to maternal, but not embryonic defects.  This speculation was 
further confirmed by reciprocal embryo transfers between Cnr1-/- and wild-type 
female mice.  Only Cnr1-/- recipients displayed oviductal retention of embryos, 
irrespective of embryonic genotypes (12). In addition, wild-type mice with 
pharmacologically inhibited CNR1, but not CNR2, also show high rates of 
embryo retention in the oviduct. Notably, Faah-/- mice, which have higher 
oviductal anandamide levels, and wild-type mice exposed to THC or 
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methanandamide (an anandamide analog) also show oviduct embryo retention 
(11). All of these observations suggest that the regulation of oviduct-uterine 
transport is not simply an up-or-down regulation of endocannabinoid signaling. 
Instead, it suggests that a finely regulated endocannabinoid tone mediated by 
CNR1 in the oviduct regulates normal embryo oviductal transport. 
 
It is known that the transport of an embryo through the oviduct is aided by a wave 
of oviduct muscle movement, ultimately controlled by the sympathetic nervous 
system (110). Stimulation of β2 adrenergic receptors (β2-AR) causes sphincter 
muscle relaxation, whereas stimulation of α1 adrenergic receptors (α1-AR) 
produces muscle contraction. It has been shown that reciprocal stimulation of 
these two receptors causes a wave of contractility and relaxation, which is 
conducive to the passage of embryos from the oviduct to the uterus (110, 111). It 
has also been found that exposure of wild-type oviducts to either an α1-AR 
agonist or a β2-AR antagonist causes embryos to be retained in the oviduct. In 
addition, Cnr1 expression in the muscularis (Figure 4b) of the oviduct is 
colocalized with α1 and β2 adrenergic receptors, and oviductal nerve terminals in 
Cnr1-/- mice have increased releases of norepinephrine (NE) (12). These 
observations lead to speculation that CNR1-mediated endocannabinoid signaling 
is functionally coupled to adrenergic signaling to regulate oviductal motility, and 
the oviductal muscularis is predominantly in a contraction phase in the absence 
of CNR1. In contrast, high levels of endocannabinoid signaling, in either Faah-/- 
mice with naturally higher anandamide levels or wild-type mice exposed to 
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excessive natural or synthetic cannabinoid ligands, cause the oviductal 
muscularis to shift to a relaxation phase, thus impairing oviductal embryo 
transport to the uterus (Figure 4c). 
 
In conclusion, the spatiotemporal expression of NAPE-PLD and FAAH in the 
oviduct creates an appropriate endocannabinoid tone, mediated by CNR1, to 
ultimately regulate the release of NE. Then, through the sympathetic nervous 
system, this signaling controls oviduct muscle contraction, consequently 
regulating oviduct-uterine embryo transport. 
 
Endocannabinoid signaling and implantation  
Attachment of the embryo to the luminal epithelium of the maternal uterus is a 
crucial step in mammalian reproduction. As the embryo travels into the uterus 
and differentiates into a blastocyst, the uterine cells undergo proliferation and 
differentiation to achieve a receptive state to accept the blastocyst for 
implantation. It is thought that blastocyst activation and uterine receptivity are two 
distinct events in the process of implantation (96), coordinated by estrogen and 
progesterone (112). Implantation can only occur when the blastocyst becomes 
implantation competent and the uterus achieves the receptive phase. The first 
attachment reaction occurs between the trophectoderm of the blastocyst and the 
uterine luminal epithelium.  
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Our laboratory has provided evidence that lower levels of AEA and CNR1 are 
beneficial for implantation. AEA levels have been measured in both receptive and 
nonreceptive uteri, with the former having a lower level of AEA compared with 
the latter (102). AEA levels are also critical in regulating preimplantation embryo 
development. In vitro experiments show that natural, synthetic or endogenous 
cannabinoids can inhibit preimplantation embryo development and blastocyst 
zona-hatching in culture, whereas blastocysts exposed to low levels of AEA show 
accelerated trophoblast differentiation and outgrowth (58, 102, 103). In vivo 
experiments show that wild-type blastocysts collected from the uterus on the 
early morning of day 4 of pregnancy have higher levels of AEA binding, and this 
binding remarkably declines in blastocysts recovered on the evening of day 4 
prior to implantation. These observations suggest that implantation competency 
requires downregulation of AEA binding to the blastocyst (104). Immunostaining 
of CNR1 confirms that CNR1 is lower in activated blastocysts, but higher in 
dormant blastocysts (56, 104). Collectively, these results show that coordinated 
down-regulation of blastocyst CNR1 and uterine AEA levels are important for 
both blastocyst activation and uterine receptivity, two events critical for 
successful implantation. 
 
To further address the underlying mechanism(s) by which differential uterine AEA 
levels are created, the expression profiles of NAPE-PLD and FAAH were 
examined in the uterus. Higher levels of Nape-pld mRNA and NAPE-PLD activity 
are found in nonreceptive uteri and in interimplantation sites, whereas both 
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mRNA and protein levels are lower in implantation sites and receptive uteri (99, 
100). It is interesting that FAAH expression and activity show an inverse 
relationship. Higher FAAH expression and activity are observed at implantation 
sites and in the receptive uteri. Evidence points toward the possibility that the 
implanting blastocyst exerts an inhibitory effect on uterine Nape-pld expression, 
and upregulates uterine FAAH activity by releasing a lipid “FAAH activator” (99, 
113). These observations suggest a potential role of the implanting embryo in 
regulating uterine AEA levels, perhaps to serve as a protective mechanism 
against exposure to detrimental levels of AEA. Regardless of its control, it is 
obvious that tight regulation of AEA plays an important role in implantation. 
 
Other studies demonstrate that endocannabinoid signaling mediated by CNR1 on 
the embryo is coupled with different downstream signaling pathways, depending 
on the concentration of AEA. For instance, it has been shown that AEA-induced 
stimulatory and inhibitory effects in blastocyst function are mediated by ERK and 
Ca2+ signaling pathways. For example, while AEA at a low concentration (7 nM) 
activates ERK signaling via CNR1, higher AEA levels (28nM) fail to activate ERK, 
but instead inhibit Ca2+ mobilization (56). These results, combined with evidence 
that women with elevated peripheral AEA levels have spontaneous pregnancy 
loss (114, 115), demonstrate that endocannabinoid signaling is at least one of 
the pathways determining the fate of implantation and ultimately successful 
pregnancy. 
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With this introduction of the role of endocannabinoid signaling in male and female 
reproduction, I present my work on endocannabinoid signaling in fertilization and 
placentation in the next two chapters. 
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CHAPTER II 
 
GENETIC LOSS OF Faah COMPROMISES MALE FERTILITY 
 
Abstract  
Marijuana is the most commonly used elicit drug. Although there is some 
indication that reproductive functions in males are impaired in chronic marijuana 
users, the genetic evidence and underlying causes remain largely unknown. 
Here we show that genetic loss of Faah, which encodes fatty acid amide 
hydrolase (FAAH), results in elevated levels of anandamide, an endocannabinoid, 
in the male reproductive system, leading to compromised fertilizing capacity of 
sperm. This defect is rescued by superimposing deletion of cannabinoid receptor 
1 (Cnr1). Retention of Faah-/- sperm on the egg zona-pellucida provides evidence 
that sperm’s capacity to penetrate the zona barrier is dampened by elevated 
anandamide levels. Collectively, the results show that aberrant endocannabinoid 
signaling via CNR1 impairs normal sperm function. Besides unveiling a new 
regulatory mechanism of sperm function, this study has clinical significance in 
male fertility.   
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Introduction 
There is some evidence that male fertility in humans is negatively regulated by 
long-term exposure to marijuana extracts (reviewed in (10)). The major 
psychoactive component of marijuana is Δ9-tetrahydrocannabinol (THC).  
Although in vitro experiments have shown that THC exerts adverse effects on 
sperm function (reviewed in (116)), there is still no in vivo or genetic evidence 
that cannabinoids impair male fertility.  After THC was identified in 1964 (14), 
research on cannabinoids exploded with the discovery and cloning of two G-
protein coupled cannabinoid receptors, brain-type Cnr1 encoding CNR1 (15, 16) 
and spleen-type Cnr2 encoding CNR2 (17). Around the same time, several 
endogenous lipid molecules targeting CNR1 and CNR2 were identified, 
collectively called endocannabinoids. The two most studied endocannabinoids 
are N-arachidonoylethanolamide (known as anandamide) and 2-
arachidonoylglycerol (2-AG) (18-20).  Anandamide levels are regulated by a 
balance between the rate of its synthesis and degradation.  Anandamide was 
thought to be produced primarily from N-arachidonoylphosphatidylethanolamine 
(NAPE) by NAPE-hydrolyzing phospholipase D (NAPEPLD) (23). However, 
genetic studies in NAPEPLD deficient mice (25) and the recent identification of 
other anandamide synthetic pathways (26, 27) have revealed that regulation of 
anandamide synthesis is more complex than previously thought. Anandamide is 
degraded to ethanolamine and arachidonic acid by a membrane-bound fatty acid 
amide hydrolase (FAAH) (28, 29). Although FAAH can hydrolyze other 
endocannabinoids including 2-AG (30), studies in Faah-/- mice show that FAAH is 
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a major player in regulating the magnitude and duration of anandamide signaling 
(27, 117). 
Sperm undergo a long journey to acquire fertilization capacity (118-120). 
Through the process of spermatogenesis, spermatogonia differentiate into highly 
polarized sperm which then undergo maturation in the epididymis before 
capacitation, acquiring motility in the female reproductive tract. After traveling 
through the uterine lumen and reaching ovulated eggs in the oviduct ampulla, 
capacitated sperm navigate through cumulus cells surrounding the egg to contact 
the zona-pellucida (zona), the outermost membrane of the egg. Upon binding to 
the zona, sperm undergo a Ca++-dependent exocytotic event known as the 
acrosome reaction which is essential for their zona penetration and homing into 
the periviteline space.  After a sperm binds to an egg plasma membrane, the two 
gametes unite, resulting in egg activation, pronuclear formation and syngamy.  
Each step in the process is essential for successful fertilization. 
There are reports that endocannabinoids and their receptors are present in 
testes and sperm of invertebrates and vertebrates, including sea urchins, frogs, 
rats, mice, boars and humans (89). This conserved expression across species 
suggests that endocannabinoid signaling plays important roles in male 
reproduction. In vitro studies also showed that endocannabinoid signaling inhibits 
capacitation of boar sperm in a cAMP-dependent pathway and prevents the 
acrosome reaction (82), and that anandamide reduces human sperm motility by 
quenching mitochondrial activity (89). However, there is no in vivo genetic 
evidence of endocannabinoid signaling impacting male reproductive functions.  
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In this study, we used gene targeted mice for Faah to mimic the conditions of 
long-term exposure to marijuana to explore roles of 
cannabinoid/endocannabinoid signaling in male fertility. 
 
Materials and Methods 
Mice 
Targeted deletion of Faah, Cnr1 or Cnr2 in mice (129/SvJ-C57BL/6J) has  
previously been described (117, 121, 122). Double mutants for Faah/Cnr1 or 
Faah/Cnr2 were generated using appropriate breeding strategies. Adult WT, 
Faah–/–, Faah–/–/Cnr1–/– and Faah–/–/Cnr2–/– mice were housed at the Institutional 
Animal Care Facility according to NIH and institutional guidelines. Experiments 
were conducted on mice between 3 and 4 months of age. Testes and epididymis 
from Faah–/– and WT males were processed for anandamide measurement and 
in situ hybridization. 
 
Western blotting 
Tissue samples were homogenized in lysis buffer [150 mmol/L NaCl, 1% NP40, 
0.5% deoxycholate, 0.1% SDS, and 50 mmol/L Tris (pH 8)] containing proteinase 
and phosphatase inhibitors. The lysates were centrifuged at 9,880 x g for 10 min 
at 4°C. Supernatants (25 µg) were boiled for 5 min in SDS sample buffer. 
Samples were run on 10% SDS-PAGE gels under reducing conditions and 
transferred onto nitrocellulose membranes. Membranes were blocked with 10% 
carnation milk in TBST and probed with antibodies against mouse FAAH (1:1000; 
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custom made by Ben Cravatt’s lab (117)), CNR1 (1:2000) (123), CNR2 (1:250; 
Cayman), β-actin (ACTB) (1:100; Santa Cruz Biotechnology), overnight at 4°C. 
After thorough washings, blots were incubated in peroxidase-conjugated 
donkey/anti-goat IgG (1:2000) or donkey/anti-rabbit IgG (1:2000; Jackson 
ImmunoResearch Lab, Inc.), followed by washings. Protein signals were detected 
using chemiluminescent reagents (Amersham). 
 
Immunohistochemistry 
Immunostaining in Bouin’s solution-fixed paraffin embedded sections (6 μm) was 
performed using antibodies specific to FAAH (1:200) (117), CNR1 (1:200) (123), 
or CNR2 (1:250; Cayman) following antigen retrieval in citrate buffer (pH 6.0) for 
10 minutes in an autoclave. A Histostain-Plus (DAB) kit (Zymed) was used to 
visualize the antigen. Reddish brown deposits indicate sites of positive 
immunostaining. 
 
Immunofluorescence 
Sperm were isolated from the epididymis of mature WT males and thoroughly 
washed in PBS. Sperm were fixed with 1% formaldehyde at room temperature for 
15 min. After blocking in 1% BSA/PBST, sperm were incubated with CNR1 
antibody (1:200; ~500ng/ml IgG)(123) with or without blocking peptide overnight 
at 4°C. After thorough washings, secondary antibodies conjugated with Cy3 
(Jackson ImmunoResearch Laboratories Inc.) were used to detect 
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immunofluorescence signaling. SYTO13 green fluorescence dye (Invitrogen) was 
used for nuclear staining. 
 
Anandamide assay 
Testes and sperm (100 mg) were pooled separately from 5 WT or Faah-/- mice in 
each group (n = 3–6) and were assayed for anandamide as previously described 
(12). Briefly, the pre-weighed samples were homogenized in ethyl acetate with 
0.5% acetic acid. 2H8-labeled anandamide was added as an internal standard to 
a mortar immediately prior to homogenization. The homogenate was centrifuged 
and the supernatant was dried, reconstituted in chloroform and purified on a 
silica-based solid-phase extraction cartridge. The eluent was dried, reconstituted 
in 1:8 of aqueous silver acetate to methanolic silver acetate and analyzed by 
reverse phase positive-ion ESI-HPLC-MS-MS. Quantification was performed by 
stable isotope dilution against the octadeuterated internal standard. 
 
In situ hybridization 
Frozen sections (12 µm) were hybridized with 35S-labeled cRNA probes for 
mouse Cnr1 or Cnr2 as previously described (124). Sections hybridized with 
sense probes served as negative controls and showed no positive signals. 
 
In vitro fertilization (IVF) 
IVF was performed as previously described (125). Briefly, WT females were 
superovulated by intraperitoneal injections of 5 IU pregnant mare serum 
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gonadotropin (PMSG, Sigma) followed by injections of 5 IU human chorionic 
gonadotropin (hCG, Sigma) 48 h later. Cumulus–oocyte complexes (COCs) were 
collected from the oviduct ampulla 12–14 h post-hCG injection and placed in 100 
µl droplets of HTF medium (Chemicon, Temecula, CA, USA). In most IVF 
experiments, zona-intact eggs were used. In some IVF experiments zona-free 
eggs were used. COCs were treated with hyaluronidase (Sigma) and cumulus-
free eggs were then exposed to acidic Tyrode’s solution and passed through a 
pipette several times until zona pellucidae were dissolved. Eggs were washed 
three times in HTF medium and incubated for >1 hour to allow surface proteins to 
recover (126). Sperm were collected from the cauda of the epididymis and 
placed into 400 ml HTF medium to allow capacitation for 2.5 h in a humidified 5% 
CO2 incubator at 37°C. Sperm (~1.2–1.5 X106 sperm/ml) were then co-incubated 
with eggs to allow fertilization. After 6 h, sperm were removed and putative 
zygotes placed in 200 µl drops of KSOM (potassium simplex optimized medium; 
Chemicon) and incubated in a humidified 5% CO2 incubator at 37oC. The 
cleavage rate (two-cell stage) after 24 h was used as an index of fertilization. 
Formation of blastocysts at 120 h indicated developmental potential of fertilized 
embryos. 
 
Evaluation of sperm-zona binding in IVF 
After sperm were incubated with eggs for 2 hours in IVF experiments, eggs were 
removed and attached sperm were stained with propidium iodide and FITC 
conjugated antibody specific to IZUMO, generated in Okabe’s laboratory (127).   
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 Analysis of acrosome reaction by flow cytometry 
WT and Faah–/– caudal sperm were incubated in the HTF medium with anti-
IZUMO antibody conjugated with FITC to monitor spontaneous acrosome 
reaction by flow cytometry at 30 minutes intervals for up to 3 h. Sperm were 
stained with propidium iodide (10 µg/ml) 2 minutes before flow cytometry analysis. 
Viable sperm were selected by propidium iodide staining, while acrosomal 
reacted sperm were identified by anti-IZUMO antibody staining (127). 
 
Evaluation of sperm motility 
After capacitation 20 µl of media containing sperm (2 X106 sperm/ml) was placed 
on a pre-warmed slide under a cover slip for 30 and 90 minutes. Sperm motility 
was recorded in 12 frames per second for 20 seconds at a resolution of 640 X 
512 pixels. The total travel distance and linear travel distance (linear distance 
from the starting point to end point) and travel time were measured by Nikon Nis-
elements’ object tracking function. The curvilinear velocity was calculated from 
the total distance traveled divided by the travel time. The linear velocity was 
calculated from the linear travel distance divided by the travel time, whereas 
linearity was calculated from the linear velocity divided by the curvilinear velocity.    
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Results 
Faah-/- males have compromised fertility 
We have previously shown that FAAH is a key metabolic regulator of 
anandamide levels in mice (117) and that FAAH deficiency results in higher 
anandamide levels in the female reproductive tract, impairing normal oviductal 
embryo transport and embryo development (27). In the course of these studies, 
analysis of breeding results showed that litter sizes generated by mating wild-
type (WT) females with Faah-/- males are 13% smaller than those resulting from 
breeding WT females with WT males (Table 1). These results suggested that 
FAAH deficiency compromises male fertility.  
 
 
Table 1. Reproductive performance of Faah-/- males  
Genotype 
♀ ♂ 
No. of litters 
examined* 
Average litter 
size (mean ± 
SEM) 
WT 30 8.1±0.4 WT       
Faah-/- 23 7.0±0.4† 
WT 21 6.3±0.2 
Faah-/-   
Faah-/- 39 4.1±0.3‡ 
Litter sizes were recorded from indicated crossing strategies. *Litters were 
produced using different males. †P=0.06. P value was generated by unpaired t-
test of litter sizes produced from breedings of WT females by Faah-/- males 
compared with those generated from breedings of WT females by WT males. 
‡P<0.001. P value was generated by unpaired t-test of litter sizes from breeding 
Faah-/- females with Faah-/- males compared to litter sizes from breeding Faah-/- 
females with WT males. 
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This is further evident from our findings of significantly reduced litter sizes 
generated by Faah-/- females mated with Faah-/- males compared to those 
generated by breeding Faah-/- females with WT males (Table 1). These breeding 
results prompted us to further examine the fertility of Faah-/- males. We used WT 
females mated with either Faah-/- or WT males. Females were killed on the 
morning of day 2 of pregnancy and oviducts flushed to record fertilized (2-cell 
embryos) and unfertilized eggs. We observed that WT females mated with Faah-/- 
males had significantly reduced numbers of fertilized eggs compared with those 
recovered from WT females mated with WT males. In addition, the number of WT 
females yielding fertilized eggs was lower (Figure 5 a & b). These data clearly 
corroborate the breeding data that FAAH deficiency impairs male fertility.  
 
 
FIGURE 5. FAAH deficiency impairs sperm fertility. (a) Number of 2-cell 
embryos per plug-positive WT females mated with WT or Faah-/- males. Numbers 
of plug-positive mice (n) used are shown within the bars. *P < 0.05, unpaired t-
test. (b) Percent 2-cell embryos and unfertilized eggs retrieved from the same 
groups. Thirteen mice were used in each group. *P < 0.01, chi square test. 
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 Collectively, our findings show that Faah-/- sperm under perform even in the WT 
female reproductive tract and that function of null sperm is further compromised 
in the Faah-/- female reproductive tract. These observations provide evidence that 
paternal FAAH deficiency is a cause for compromised fertility. 
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FIGURE 6.  FAAH and CB receptors are expressed in the male reproductive 
tract. (a) Western blotting of CNR1, CNR2 and FAAH in the WT testis and 
epididymis. Brain tissue extracts served as positive controls for CNR1 and FAAH, 
while spleen tissue samples as positive controls for CNR2. ACTB is a loading 
control. Epi, epididymis. (b) Immunolocalization of CNR1, CNR2 and FAAH in the 
testis and epididymis. Bar, 50 μm. L, Leydig cells. (c) CNR1 immunostaining (red) 
in sperm (left 3 panels); sperm exposed to CNR1 antibody pre-absorbed with an 
antigenic peptide (right 3 panels). In each group, CNR1 staining, nuclear staining 
and merged pictures were showed from left to right. Nuclei were counter-stained 
with Cyto-13 (green). H (arrowhead) indicates sperm head, while MP (arrow) 
indicates sperm midpiece. Nu, nuclear. Bar, 10 μm. 
 
Endocannabinoid signaling is present in the male reproductive system 
The extent and duration of anandamide signaling via CNR1 and/or CNR2 is 
mainly regulated by FAAH (117). Thus, we examined the expression of CNR1, 
CNR2 and FAAH in the testis and epididymis to study potential roles of 
anandamide in regulating male fertility. Western blotting analysis showed that 
FAAH, CNR1 and CNR2 are present in both the testis and epididymis of WT 
mice (Figure 6a). We next examined cell - specific localization of FAAH and CB 
receptors in the testis and epididymis of WT mice by immunohistochemistry 
(Figure 6b). We found that while CNR1 was present in Leydig cells and 
epididymal epithelial cell surfaces, testicular spermatocytes and spermatids 
showed modest positive staining. In contrast, CNR2 was localized in 
spermatocytes and Sertoli cells encircling spermatocytes/spermatids in the testis. 
In the epididymis, epithelial cell surfaces were decorated with CNR2 
immunostaining, whereas signals were undetectable in interstitial cells. FAAH 
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was present in spermatocytes and spermatids, while spermatogonia had little or 
no positive signals. Sertoli cells and Leydig cells also showed positive staining of 
FAAH. The localization of FAAH was clearly evident on cell surfaces of the 
e p i d i d y m a l  e p i t h e l i u m .  T h e  a n t i b o d y  s p e c i f i c i t y  w a s  
 
FIGURE 7. FAAH protein is absent in Faah-/- testis and epididymis. 
Immunostaining of FAAH in the testis and epididymis of WT and Faah-/- mice. Epi, 
epididymis. Bar, 50μm. 
 
confirmed using Faah-/- tissues (Figure 7). The presence of FAAH on both the 
testis and epididymis suggests that endocannabinoid levels in these tissues are 
tightly regulated by FAAH.  
The presence of CNR1 and CNR2 on sperm was also examined by 
immunofluorescence. As shown in Figure 6c, CNR1 immunofluorescence is 
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primarily noted in anterior regions of sperm heads, the site of the acrosomal sac, 
but also in the midpiece.  CNR1 is undetectable in the principle and end piece of 
sperm tails. Sperm incubated with CNR1 antibody pre-absorbed with an 
antigenic peptide showed that while the signal in the anterior region of sperm 
heads is specific, the signal is non-specific in the midpiece (Figure 6c). 
Interestingly, CNR2 was undetectable in sperm (Figure 8).  Our findings of the 
presence of FAAH, CNR1 and CNR2 in the testis and epididymis, and that of 
FAAH and CNR1 in sperm, would suggest that endocannabinoid signaling plays 
a role in spermatogenesis and sperm maturation.  
 
 
FIGURE 8. CNR2 is undetectable in sperm. Non-specific fluorescence (red) 
was noted in the midpiece of both WT and Cnr2-/- sperm. Bar, 10μm. 
 
FAAH deficiency elevates anandamide levels in the testis and epididymis 
To provide genetic evidence for FAAH’s function in the male reproductive system, 
we measured anandamide and 2-AG levels in the testis and epididymis of WT 
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and Faah-/- mice using reverse-phase high-performance liquid 
chromatography/tandem mass spectrometry. As shown in Figure 9a, the testis 
and epididymis from Faah-/- mice had significantly increased anandamide levels, 
suggesting that FAAH is a primary enzyme that regulates anandamide turnover 
in these tissues. Higher testicular anandamide levels in Faah-/- males corroborate 
our previous observation (128).  However, levels of 2-AG in the testis and 
epididymis were comparable between Faah-/- and WT males (Figure 9a). These 
results are consistent with our previous data in the uterus, showing unaltered 2-
AG levels in the absence of FAAH (27). 
 
FIGURE 9.  FAAH deficiency elevates anandamide levels. (a) Anandamide, 
but not 2-AG, levels in Faah-/- testis and epididymis were higher than those in WT 
(n=10; *P < 0.05, unpaired t-test). (b) Western blotting of CNR1, CNR2 and 
FAAH in the testis and epididymis of WT and Faah-/- males. Brain and spleen 
samples served as positive controls, while ACTB served as a loading control. Epi, 
epididymis. Br, brain. Sp, spleen. 
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Higher anandamide levels in the Faah-/- testis and epididymis prompted us to 
speculate that reduced fertility in these males is due to persistent and/or elevated 
endocannabinoid signaling. However, it is possible that there is a negative 
feedback loop to downregulate the expression of CB receptors to counter the 
consequence of high anandamide levels. To address this possibility, we 
examined the status of CB receptors in the testis and epididymis of WT and 
Faah-/- mice by Western blotting. As shown in Figure 9b, levels of CNR1 and 
CNR2 protein in these tissues were comparable between Faah-/- and WT males. 
These results suggest that higher anandamide levels do not appreciably 
downregulate CNR1 or CNR2 expression. To further confirm that expression of 
CNR1 and CNR2 is not altered in Faah-/- males, in-situ hybridization and 
immunohistochemistry were performed. Expression patterns of both CNR1 and 
CNR2 were similar in WT and Faah-/- epididymis (data not shown). Collectively, 
the data suggest that the status of CB receptors is not altered by higher 
anandamide levels and that heightened signaling via CNR1 and/or CNR2 occurs 
in the presence of increased anandamide levels. 
 
FAAH deficiency impairs sperm fertilizing capacity 
Our in vivo breeding data led us to speculate that higher anandamide levels in 
males lacking FAAH results in their reduced fertility. To examine this, we first 
compared histology of the testis and epididymis as well as sperm morphology 
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between Faah-/- and WT males at the age of 3-4 months. To our surprise, no 
apparent histological abnormalities were observed in these tissues missing Faah 
(Figures 10). We next explored whether FAAH deficiency in males impairs 
sperm’s fertilizing capacity by performing in vitro fertilization (IVF) experiments 
using Faah-/- or WT sperm with WT eggs. Sperm retrieved from the caudal 
epididymis were subjected to capacitation in vitro for two hours before placing 
them with eggs in culture. The fertilization rate was calculated by counting the 
number of 2-cell embryos developed on the second day after IVF. As shown in 
Table 2, sperm retrieved from WT males showed a 75% fertilization rate with 
97% of 2-cell embryos developing to blastocysts. In contrast, Faah-/- sperm 
showed remarkably a reduced fertilization rate (42%), although development of 
fertilized eggs into blastocysts was comparable (89%) to those of WT (97%). 
These results suggest that the fertilizing capacity of Faah-/- sperm is 
compromised due to impairment in the male reproductive tract before ejaculation, 
since no exogenous anandamide was added to the capacitation medium. 
 
 
Table 2.  Higher anandamide levels impair sperm fertilizing capacity in vitro via    
CNR1. 
Genotypes 
No. of 
eggs used 
for IVF 
% IVF rate (No. of 2-
cell embryos/total No. 
of eggs used)  
% development (No. of 
blastocysts /total no. of 
2-cell embryos used) 
WT 624 75 (466/624) 97 (450/466) 
Faah-/- 528 42 (221/528)* 89 (197/221) 
Faah-/-/Cnr1-/- 177 70 (124/177) 93 (115/124) 
Faah-/-/Cnr2-/- 118 11 (13/118)*      84.6 (11/13) 
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IVF rates of WT eggs fertilized by sperm of different genotypes were recorded on 
day 2 post-fertilization. The rate of blastocyst formation from 2-cell embryos was 
evaluated on the 5th day of culture. Fertilizing capacity of Faah-/- or Faah-/-/Cnr2-/- 
sperm was significantly lower than WT sperm (*P<0.01; χ2-analysis). 
 
 
 
FIGURE 10. The histology of Faah-/- testis and epididymis is comparable to 
those of WT mice. H&E staining of the testis, caput and cauda sections from 
Faah-/- males show histology similar to WT males. Bar, 100μm. 
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Deletion of Cnr1 reverses impaired fertilizing capacity of Faah-/- sperm 
Sustained higher anandamide levels in the male reproductive tract lacking FAAH 
are capable of exerting endocannabinoid signaling either through CNR1, CNR2 
or both. To address this question, we generated Faah-/-/Cnr1-/- and Faah-/-/Cnr2-/- 
double mutant mice. We again performed IVF using sperm retrieved from Faah-/-
/Cnr1-/- or Faah-/-/Cnr2-/- males with eggs isolated from WT females. As shown in 
Table 2, sperm isolated from Faah-/-/Cnr1-/- males exhibited a 70% fertilization 
rate with 93% of fertilized eggs developing to the blastocyst stage, but sperm 
isolated from Faah-/-/Cnr2-/- males showed a remarkably low fertilization rate 
(11%). These data show that in the absence of CNR1, Faah-/- sperm escape the 
deleterious effects of higher anandamide levels. It is interesting to note that Faah-
/-/Cnr2-/- sperm had a more inferior fertilizing capacity than Faah-/- sperm. The 
results provide genetic evidence that higher anandamide levels work through 
CNR1 in the Faah-/- male reproductive tract to impair sperm fertilizing capacity.  
 
Faah-/- sperm have poor zona-penetrating ability 
Our next objective was to see which step in the fertilization process is impaired in 
Faah-/- sperm. We first examined whether Faah-/- sperm can adhere to zona-
pellucidae and if so, whether they can undergo acrosome reaction. IZUMO, a 
recently discovered protein, is not displayed on plasma membranes of acrosome-
intact sperm (127). Following acrosome reaction, IZUMO is exposed and 
participates in sperm-egg fusion. Thus, only acrosome-reacted sperm are stained 
by the IZUMO antibody.   
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WT or Faah-/- sperm were incubated with WT eggs for 2 hours and then 
stained with propidium iodide to label cell nuclei. We found that after the 2-hour 
incubation most WT sperm detached from the zona surface (Figure 11a), 
whereas numerous Faah-/- sperm were still attached to the zona. Even after 
several washings, Faah-/- sperm remained adherent to the zona indicating good 
binding of Faah-/- sperm to the zona. These results suggested that most eggs 
were fertilized by WT sperm, but eggs incubated with Faah-/- sperm were still 
unfertilized. We then stained the sperm attached to eggs with the IZUMO 
antibody.  
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 FIGURE 11. Zona-penetrating capacity of Faah-/- sperm is inferior. (a) 
Sperm-egg interactions using zona-intact WT eggs. After 2 hours of incubation 
with eggs, Faah-/- sperm were still attached to zona pellucidae. Bar, 40μm. Arrow 
heads indicate sperm on the zona-intact egg surface; e, egg. (b) Spontaneous 
acrosome reaction as assessed by flow cytometry. Rate (%) of acrosome-
reacted WT and Faah-/- sperm at each time point was analyzed by flow cytometry 
as described in the methods and no statistically significant difference was noted 
between the two groups as analyzed by student t test. (c) IVF rates of zona-free 
WT eggs fertilized by WT or Faah-/- sperm. Numbers above the bars indicate the 
number of fertilized eggs/total zona-free eggs used for IVF. 
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Many Faah-/- sperm remaining on the zona surface showed positive signal by 
the IZUMO antibody (figure 12), indicating they underwent acrosome reaction. To 
further confirm that Faah-/- sperm undergo normal acrosome reaction, we 
examined the spontaneous acrosome reaction rate of Faah-/- sperm. The 
acrosome reaction, which occurs during sperm penetration through the zona, can 
also occur spontaneously without binding to the zona. Analysis of spontaneous 
acrosome reaction is used to assess the fertilizing ability of human (129) and 
mouse sperm (130). We compared the status and time-course of spontaneous 
acrosome reaction of WT and Faah-/- sperm in the fertilization medium by flow 
cytometry. While viable sperm were selected by propidium iodide staining, 
acrosome-reacted sperm were identified by IZUMO staining. As shown in figure 
11b, the percentage of acrosome-reacted Faah-/- sperm is somewhat lower than 
that of WT acrosome-reacted sperm, but the difference is not statistically 
significant. Collectively, these data suggest that Faah-/- sperm can bind to the 
zona and undergo acrosome reaction, but still have difficulty fertilizing eggs. 
The acrosome reaction is not the only prerequisite for zona penetration: 
sperm motility and acrosomal release of proteases are also involved in this 
process (120). To examine whether Faah-/- sperm can penetrate the zona 
successfully, we performed IVF using sperm from Faah-/- or WT mice incubated 
with zona-free WT eggs. To our surprise, Faah-/- sperm exhibited a comparable 
fertilizing capacity with WT sperm (Figure 11c), indicating that the zona is a major 
barrier for normal fertilization by Faah-/- sperm.  
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 FIGURE 12. Immunofluorescence of IZUMO in sperm. After 2 hours of 
incubation with zona-intact WT eggs, sperm on the zona were stained with 
propidium iodide (red) and with an antibody to IZUMO (green). Arrowheads 
indicate acrosome-reacted sperm on eggs. Bar, 40μm. E, egg; c, cumulus cells. 
 
Sperm motility is attenuated in Faah-/- males 
It is generally accepted that robust sperm motility is an important component of 
normal male fertility (131), and that hyperactivated sperm motility is correlated 
with sperm’s ability to fertilize zona-intact eggs (132). In a low viscosity medium, 
motility of hyperactivated sperm is characterized by asymmetrical flagellar bends 
with larger amplitude and curvature, and moving trajectories that are irregular 
and highly curved (133). We often observed sluggish motility of Faah-/- sperm 
when they were incubated in the capacitation medium. We speculated that the 
reduced zona-penetrating ability of Faah-/- sperm could be due to their reduced 
motility and/or hyperactivation. Therefore, we assayed motility of WT and Faah-/- 
sperm after capacitation for 30 and 90 minutes in vitro. In this measurement, the 
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curvilinear velocity was calculated from the total distance traveled divided by the 
travel time; this parameter indicates sperm’s swimming ability. The linear velocity 
was calculated from the distance between the start and end points divided by the 
travel time. The linearity is the ratio of linear velocity over the curvilinear velocity; 
this is an indicator of straightness of sperm movement.  
 
 
FIGURE 13. Motility of Faah-/- sperm is inferior. (a) Curvilinear velocity of WT 
and Faah-/- sperm. Curvilinear velocities of Faah-/- sperm were significantly lower 
than those of WT at 30 and 90 minutes of capacitation. (*P < 0.01, unpaired t-test) 
(b) Linear velocity of WT and Faah-/- sperm. Linear velocities of Faah-/- sperm 
were significantly lower than those of WT sperm (*P < 0.05, unpaired t-test). (c) 
Linearity of WT and Faah-/- sperm. Linearity of Faah-/- sperm was significantly 
lower than WT sperm at 30 minutes of capacitation. (*P < 0.05, unpaired t-test). 
 
The movement of Faah-/- sperm was significantly slower than those of WT 
sperm both at 30 and 90 minutes of incubation in the capacitation medium 
(Figure 13a). The movement of WT sperm was primarily straight at 30 minutes of 
capacitation with symmetrical flagellar beats. After 90 minutes of capacitation, 
WT sperm showed a hyperactivated movement pattern, resulting in reduced 
linear velocity (Figure 13b) and linearity (Figure 13c); the curvilinear velocity was 
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not significantly changed (Figure 13a). However, Faah-/- sperm demonstrated 
irregular movement at 30 minutes of capacitation distinguished by low linear 
velocity and linearity (Figure 13b and 13c). Although their moving trajectories 
were erratic, the seemingly hyperactivated movement of Faah-/- sperm was not 
the consequence of harder beating of flagellum after capacitation, because the 
moving speed of Faah-/- sperm stayed at low levels. These results show that 
heightened anandamide signaling in the male reproductive tract compromises 
motility of Faah-/- sperm, leading to reduced zona-penetration and fertilization.  
 
Discussion 
Emerging evidence shows that endocannabinoid signaling plays critical roles in 
reproduction. Endocannabinoid signaling is operative in the oviduct, uterus and 
embryo, and aberrant endocannabinoid signaling adversely affects oviductal 
transport of embryos and their development (10). Consistent with our present 
findings, endocannabinoids and their receptors were reported to be present in 
the testis and sperm of both invertebrates and vertebrates (68, 69, 79, 82, 89, 
134).  However, our studies showing the presence of the endocannabinoid 
system in different regions along the male reproductive tract suggests that 
endocannabinoid signaling has diverse physiological functions. In this respect, 
Sertoli cells exposed to higher anandamide levels were shown to undergo 
apoptosis (74), and FAAH activity is regulated by follicle stimulating hormone in 
mouse sertoli cells (135). In addition, sperm fertility and acrosome reaction were 
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reported to be adversely affected if exposed in vitro to high anandamide levels 
(77, 89). 
   Although these in vitro studies suggested a role for endocannabinoids in male 
reproduction, our experiments were designed to see in vivo effects of sustained 
higher anandamide levels in the male reproductive tract on various aspects of 
sperm function.  We used Faah-/- mice with higher anandamide levels as a model 
system to mimic the conditions of long-term exposure to marijuana to explore the 
role of cannabinoid/endocannabinoid signaling in male fertility. Results of our IVF 
experiments with Faah-/- sperm show a resemblance to reduced sperm fertilizing 
capacity and motility in marijuana users (136-138). Our findings of compromised 
fertilizing capacity of Faah-/- sperm in vivo and in vitro as well as their inability to 
recover in normal capacitating medium provide strong evidence that functional 
impairment of sperm exposed to higher anandamide levels in vivo persists for a 
prolonged period or becomes irreversible. Our results are clinically relevant since 
long-term in vivo exposure to marijuana is implicated in reduced male fertility 
(136-138).  
IVF experiments using zona-free eggs is an established method to study 
cellular mechanisms of gamete adhesion and fusion (139). Using this strategy, 
here we have shown that Faah-/- sperm are capable of adhering to and fusing 
with zona-free eggs similar to WT sperm. The fact that the fertilization rate of 
Faah-/- sperm increased from 42% with zona-intact eggs to 90% with zona-free 
eggs suggests that the zona is a major barrier to Faah-/- sperm, since these null 
sperm display comparable spontaneous acrosomal reaction rates to WT sperm 
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as evident from IZUMO staining and flow cytometry analysis. We speculate that 
factors other than the acrosomal reaction weaken the sperm’s penetrating 
capacity through the zona. Sperm motility and acrosomal enzymes are both 
involved in zona penetration (120). It is possible that contents released from the 
acrosomal sac lack appropriate protease activity required for penetration, or that 
Faah-/- sperm cannot acquire hypermotility following capacitation. Our results 
suggest that reduced motility is a contributing factor for the reduced zona-
penetrating ability of Faah-/- sperm. However, other factors such as protease 
activity may also contribute to sperm’s reduced capacity for zona penetration. It 
is interesting to note that Faah-/- sperm show asymmetric flagellar beats at 30 
minutes of capacitation. We still do not know whether Faah-/- sperm show 
straight-forward moving trajectory before 30 minutes of capacitation. Although it 
would be interesting to know the motility of Faah-/- sperm right after they are 
placed in the capacitation medium, we were unable to acquire this information 
because of the time necessary for sperm manipulation and counting.  
Reversal of the defects of FAAH deficiency in the absence of CNR1 suggests 
that anandamide signaling exerts its effects on sperm through CNR1. Since 
CNR1 is expressed in the testis, epididymis and sperm, it is not clear where and 
how CNR1-mediated signaling regulates sperm fertility. Since sperm display 
CNR1, it is possible that higher anandamide levels directly target sperm to alter 
their function.  Alternatively, heightened signaling via CNR1 in the presence of 
higher anandamide levels in Faah-/- testis and epididymis perhaps changes the 
internal milieu to affect sperm maturation, affecting sperm fertility. Our findings 
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that Faah-/-/Cnr2-/- sperm show inferior fertilizing capacity compared to sperm 
deleted of Faah-/- only suggests that anandamide working via CNR2 is important 
for normal sperm fertility. Alternatively, in the absence of CNR2, higher levels of 
anandamide are exclusively available to CNR1  which may further enhance its 
adverse effects on sperm function. The latter speculation seems more probable, 
since homozygous crossings of Cnr2-/- mice have an average litter size of about 
7 (n=6), whereas homozygous crossings of Faah-/-/Cnr2-/- produces an average 
of 4 pups per litter (n=12). Although breeding data are confounded by maternal 
factors other than IVF results, this observation suggests that CNR2 has limited 
roles in sperm function under normal physiological anandamide levels.   
The present investigation has high physiological significance, since sperm in 
Faah-/- males and those in chronic marijuana users are all subjected to enhanced 
cannabinoid/endocannabinoid signaling. Beneficial effects of anandamide in 
neurodegeneration, cancer, pain and anxiety (140-143) have prompted 
increasing interest and effort in developing FAAH inhibitors as novel therapeutic 
drugs. Thus, the adverse effects of anandamide should be carefully weighed 
against its beneficial effects. This study provides insights into male fertility 
regulation by endocannabinoid signaling, and may shed light on improving male 
fertility.  
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CHAPTER III 
 
ENDOCANNABINOID SIGNALING DIRECTS DIFFERENTIATION OF 
TROPHOBLAST CELL LINEAGES AND PLACENTATION 
 
Abstract 
Placentation is critical for fetal development. Exposure to marijuana during 
pregnancy has adverse effects, but it is not known if the placenta is a target of 
cannabinoid/endocannabinoid signaling. Using mice as a model organism, we 
found that the endocannabinoid system is present in the ectoplacental cone and 
spongiotrophoblast cells. We also observed that aberrant endocannabinoid 
signaling confers premature trophoblast stem cell differentiation, and defective 
trophoblast development and invasion. These defects are reflected in retarded 
fetal development and elevated spontaneous pregnancy loss. Because the 
endocannabinoid system is conserved across species, including humans, our 
study suggests that endocannabinoid signaling is critical to placentation and 
pregnancy success in humans. 
 
 
 
 
 55
Introduction 
In eutherians, the placenta is the sole bridge between the mother and fetus. 
While maternal resources filtered across the selective barrier of the placenta 
nourish and protect the conceptus, the placenta also reshapes the maternal 
physiology to facilitate fetal survival. Most placental functions are attributed to 
various trophoblast cell lineages: trophoblast giant cells, spongiotrophoblast, 
syncytiotrophoblast and glycogen trophoblast cells (144). The fact that all 
trophoblast cell types are derived from trophoblast stem (TS) cells suggest that 
differentiation of TS cells is a finely tuned process (145). An appropriate ratio of 
different trophoblast cell types is a prerequisite for normal placentation, and any 
aberration in trophoblast differentiation compromises normal placentation.  
 
In mice, immediately after implantation, the mural trophectoderm penetrates 
the uterine stroma, forming primary trophoblast giant cells (TGC). The polar 
trophectoderm, which is adjacent to the inner cell mass, forms the 
extraembryonic ectoderm and ectoplacental cone (EPC), in which progenitor 
cells that differentiate into secondary trophoblast giant cells reside. Both primary 
and secondary giant cells undergo multiple rounds of endoreduplication, resulting 
in cells with polyploid nuclei (146, 147). The EPC and extraembryonic ectoderm 
cells remain diploid, and give rise to the spongiotrophoblast and labyrinth layers 
of the placenta (145). In vivo, the progenitor cells in the extraembryonic ectoderm 
and EPC generate chorionic trophoblasts or spongiotrophoblasts (SPT). 
However, in vitro TS cells primarily differentiate into TGC, leading to the concept 
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that while differentiation to the giant cell lineage is a default pathway, 
differentiation to other lineages requires distinct signals (94). 
       
Endocannabinoid signaling is a critical regulator of various pregnancy events 
in mice and humans. Abnormal cannabinoid/endocannabinoid signaling leads to 
a series of defects that are reflected in embryo development, oviductal transport 
of embryos, implantation, parturition and early fetal loss in mice (12, 104, 148-
151).  There is evidence that the endocannabinoid system is also present in the 
human placenta (152, 153). However, the definitive role of endocannabinoid 
signaling in placentation remains undefined. 
 
Endocannabinoid signaling is normally mediated by two G-protein coupled 
cannabinoid receptors, CNR1 (15, 16) and CNR2 (17). Several endogenous 
bioactive lipid molecules targeting CNR1 and CNR2 have been identified, 
collectively called endocannabinoids. To date, most work on endocannabinoid 
signaling has focused on the roles of anandamide (AEA) and 2-
arachidonoylglycerol (2-AG) (18-20).   AEA levels are regulated by a balance 
between the rate of its synthesis and degradation. Several AEA synthetic 
pathways have recently been identified (23, 26, 27). The presence of multiple 
pathways provides evidence that the regulation of AEA synthesis is complex.  
AEA is degraded to ethanolamine and arachidonic acid by a membrane-bound 
fatty acid amide hydrolase (FAAH) (28, 29). Although FAAH can hydrolyze other 
endocannabinoids including 2-AG (30), studies in Faah-/- mice show that FAAH is 
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the major player regulating the magnitude and duration of anandamide signaling 
(27, 117). 
 
Cannabinoid receptors have been cloned from various species, including the 
sea urchin, fish, leech, cat, dog, bovine, mouse and human (154). The 
evolutionary conserved nature of the endocannabinoid system across species 
from invertebrates to vertebrates suggests its important biological functions. 
Studies indicate that mice and humans have many similarities regarding the 
regulation of endocannabinoid signaling and its physiological roles. For instance, 
successful implantation requires tightly regulated anandamide signaling in both 
mice and humans (10, 104, 155). The absence of CNR1 in mice causes oviductal 
retention of preimplantation embryos (156), while women with ectopic pregnancy 
have attenuated expression of CNR1 in the Fallopian tube (157).  
 
Previous studies have shown the presence of the endocannabinoid system in 
the human placenta (158). However, the underlying mechanism of 
endocannabinoid signaling affecting pregnancy success is not known. In this 
study, we used a genetic approach to address this question. We found 
midgestational fetal loss in mice missing Cnr1. Further in vivo and in vitro studies 
show that CNR1 deficient TS cells fail to appropriately differentiate to normal 
placentation, leading to midgestational fetal demise and compromised pregnancy 
outcome. 
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Materials and Methods 
Reagents 
Antibodies to anti-CNR1 (N-15) antibody were purchased from Santa Cruz 
Biotechnology; anti-cytokeratin antibody was from DAKO Diagnostics; anti-
phospho-AKT (Ser-473 or 308) was from Cell Signaling. Anti-FAAH antibody was 
a gift from Dr. Benjamin F. Cravatt (The Scripps Research Institute, CA). 
SR141716 and SR144528 were dissolved in ethanol and diluted to a final 
concentration with ethanol less than 0.1%.  
 
Animals  
Adult wild-type, Cnr1 and Faah mutant mice on C57BL/6J genetic background 
generated as previously described (117, 159) were housed in the animal care 
facility of Cincinnati Children’s Hospital Medical Center according to National 
Institutes of Health and institutional guidelines for laboratory animals.  Female 
mice were mated with fertile males and were checked for vaginal plug at 0900h 
for confirmation of pregnancy (day 1). To examine the postimplantation 
development of embryos, mice were killed between 0900-1000h on the given day 
as described in the paper and implantation sites were weighed, then frozen or 
fixed for further study. Some implantation sites of day 12 and 14 were dissected 
out to weigh the placenta and fetus. 
 
In situ and Northern hybridization 
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In situ hybridization and Northern blotting were performed as previously 
described (124). Antisense 35S-labeled or 32P-labeled cRNA probes produced 
from specific cDNA were used to detect the specific mRNA on frozen sections or 
membranes. The densities of Northern bands were quantified using Scion Image 
software.  
 
Trophoblast Stem (TS) Cell Culture 
Wild-type or Cnr1-/-Cnr2-/- trophoblast stem cell (TS) lines were generated as 
previously reported (160).  Cells were maintained in a proliferative state in media 
(TS maintaining media) containing 70% embryonic mouse fibroblast cells 
conditioned medium, 30% TS cell medium, 25ng/ml FGF4 and 1 µg/ml heparin, 
incubated in a humidified tissue culture incubator at 37˚C, 5% CO2 atmosphere. 
To introduce TS cell spontaneous differentiation, cells were cultured in medium 
without conditioned medium, serum, FGF4 and heparin for up to 6 days with 
medium changed everyday.  
 
BrdU (5-Bromo-2'-deoxyuridine) incorporation  
Two hours before sacrifice, animals were injected intraperitoneally with BrdU 
reagent (catalog No. 00-0103, Invitrogen, CA) at 1ml/100 gram body weight. 
Implantation sites were fixed in 10% neutral buffered formalin, and embedded in 
paraffin. The Brdu signals on paraffin sections were detected using the BrdU 
staining kit (catalog No. 93-3943, Invitrogen, CA), following the manufacturer’s 
protocol. 
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 Proliferation assay 
The proliferation assays of the wild-type or Cnr1-/-Cnr2-/- TS cells were performed 
using the Cell Proliferation Assay kit (Promega). In brief, TS cells (0.5, 1, 2 X 103 
cell/100 µl well) were suspended in TS maintaining media, seeded on to 96-well 
plates and incubated until analyzed. At different time points, mixed MTS/PMS 
solution (20µl/well) was added and incubated for 4 hours and then absorbance 
read at 490 nm under an ELISA plate reader (Bio-TEK). The proliferation assay 
was performed on counted cells seeded for 1 hour to determine the correlation 
coefficients of absorbance-cell number standard curves. The cell numbers at 
different time points were calculated by the coefficient using standard curves. 
The assays were performed in triplicate and the experiments were repeated 
three times. 
 
Invasion assay 
The invasion assays were performed in 24-well BD Biocoat Matrigel invasion 
chambers following the manufacturer’s instructions. In brief, Matrigel inserts 
rehydrated with RPMI1640 medium were placed over the BD Falcon TC 
companion plate containing 0.75 ml/well TS maintaining media. Wild-type or 
Cnr1-/-Cnr2-/- TS cells were suspended in TS maintaining media with different 
treatments but minus condition medium and serum at a density of 10 X 104 
cell/ml. Then 0.5 ml cell suspensions were seeded within the Matrigel inserts 
immediately. After 22 or 44 hours incubation, the Matrigel and non-invading cells 
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are removed by cotton swab from the upper surface of the membrane of the 
inserts. The invaded cells at the lower surface of the membrane were then fixed 
with 10% neutral buffered formalin and stained with crystal violet. After air drying, 
the cells could be counted or a picture taken under an inverted microscope.  The 
assays were performed in triplicate and the experiments were repeated three 
times. 
 
Statistical Analysis 
Comparison of means was performed using Student’s t test. Data are shown as 
mean ± SEM. 
 
Results 
Genetic loss of Cnr1 compromises pregnancy success in mice 
 Endocannabinoid signaling is a key player in regulating female fertility. Our 
previous studies have shown that about 30% of embryos are trapped in the 
oviduct of Cnr1-/- mice (12). In addition, our breeding data of Cnr1-/-  females 
crossed with Cnr1-/- males show a 50% reduction in litter sizes compared to 
crosses between wild-type (WT) females and males (Figure 14a). This dramatic 
reduction in litter sizes suggests that approximately 20% of embryos are lost 
during gestation, considering that 30% of embryos are trapped in the oviduct. 
Moreover, 40% of plug-positive Cnr1-/- females did not produce any litters (12), 
underscoring the fact that embryo loss during gestation is even more severe.   
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 FIGURE 14. Cnr1-/- mice have compromised placentation, embryo 
development and pregnancy outcome. (a) Cnr1-/-, but not Cnr2-/-, mice have 
smaller litter size (unpaired t-test, *P<0.05). (b) A higher rate of resorptions is 
seen in Cnr1-/- mice on days 12 and 14 of pregnancy (F-test, *P<0.05). (c) Cnr1-/- 
implantation sites (IS) weigh less than those of WT at midgestation (unpaired t-
test, *P<0.05). (d) Average weights of Cnr1-/- placenta are less than those of WT 
on days 12 and 14 of pregnancy (unpaired t-test, *P<0.05). Numbers within bars 
indicate numbers of dams examined. 
 
In order to determine the stage when the sign of resorption is clearly evident, 
we examined the pregnancy status on days 10 through 14 in Cnr1-/- and WT 
females. We found that a higher rate of resorption occurs on days 12 and 14 of 
pregnancy in mutant females (Figure 14b). Furthermore, weights of implantation 
sites in Cnr1-/- females are less than those in WT mice (Figure 14c). Since 
placentation occurs during this period, we also recorded placental weights. 
Placental weights in Cnr1-/- mice are also significantly lower than those in WT 
mice (Figure 14d). These results prompted us to hypothesize that CNR1 
deficiency causes placentation defects, and thus fetal death during midgestation. 
 
Endocannabinoid system is present in midgestational placentas 
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To investigate the role of the endocannabinoid system in midgestation, we first 
measured the levels of the two most studied endocannabinoids, AEA and 2-AG, 
which target CNR1 evoking various biological functions. We found that the levels 
of both AEA and 2-AG are comparable between WT and Cnr1-/- females in day 
12 uteri and placentas (Fig 15a). Furthermore, the expression pattern of CNR1 
was examined by immunohistochemistry. We found that CNR1 positive cells are 
present in the EPC on day 10 of pregnancy. On day 14, CNR1 is expressed in 
the SPT layer which is derived from the EPC (Fig 15b). FAAH showed 
expression patterns similar to CNR1 (Fig 15c). The presence of endocannabinoid  
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FIGURE 15. Endocannabinoid system is present in midgestational 
placentas. (a) Levels of AEA and 2-AG are comparable in WT and Cnr1-/- 
midgestational uteri and placentas. Uterine and placental samples were pooled 
separately from 5 pregnant WT or Cnr1-/- mice in each group (n = 4-5) (b) CNR1 
is present in trophoblast cells in the EPC on day 10 of pregnancy and SPT layer 
on day 14 of pregnancy. (c) FAAH expression pattern is similar to CNR1 in 
midgestational placentas. Results are representative of at least 2 to 3 
independent samples. EPC, ectoplacental cone; CP, chorionic plate; Dec, 
decidua basalis; Sp, spongiotrophoblast; Lab, labyrinth. 
 
ligands, receptors and a key regulatory enzyme in midgestation placentas 
suggests that endocannabinoids play an important role in placentation. 
Additionally, the restricted expression of CNR1 and FAAH within the EPC, and 
thereafter in the SPT, led to the speculation that generation, differentiation, 
and/or maintenance of SPT cells is regulated by endocannabinoid signaling, and 
an aberration of this signaling, as in CNR1 deficiency, leads to abnormal 
placentation. 
 
Spongiotrophoblast development is compromised in Cnr1-/- mice 
To better understand the underlying cause of midgestational embryo loss in the 
absence of CNR1, we analyzed placental development in WT and Cnr1 null mice. 
Placental lactogen I (Pl1), encoding the prolactin-like hormone, is specifically 
expressed in TGC (161), while trophoblast-specific protein α (Tpbpa, also known 
as 4311) is explicitly expressed in SPT cells (162). In situ hybridization results 
show that Pl1 expression in Cnr1-/- placentas on day 10 of pregnancy is 
comparable to that in WT mice (Figure 16a). However, Tpbpa expression is 
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appreciably reduced in Cnr1-/- placentas, providing evidence that the 
development of the SPT layer has been compromised. These results are 
consistent with Northern hybridization results, showing much higher Tpbpa 
expression in WT mice compared with Cnr1-/- mice on day 10 of pregnancy. Pl1 
expression levels are similar in Cnr1-/- and WT females on the same day (Figure 
16b).       
 
 
FIGURE 16. Cnr1-/- spongy layer is developmentally compromised.  (a) While 
numbers of Tpbpa positive cells are considerably lower in Cnr1-/- placentas, Pl1 
expression in Cnr1-/- placentas on day 10 is comparable to that in WT placentas. 
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Scale bar: 500 μm. (b) Northern blotting results using RNA samples from WT and 
Cnr1-/- implantation sites on day 10 of pregnancy show that Tpbpa, but not Pl1, 
levels are reduced. Levels of Tpbpa and Pl1 mRNAs were normalized and 
quantified against Rpl7 (a house-keeping gene) band intensities using the same 
membrane. (c) Levels of mash2 transcript were reduced in Cnr1-/- placentas, but 
Hand1 levels were comparable in WT and Cnr1-/- placentas. Scale bar: 500 μm. 
Secondary TGCs are differentiated from precursor cells present in the EPC 
and later in the SPT layer. The terminal differentiation of precursor cells is 
regulated by a reciprocal interaction between two basic helix-loop-helix 
transcription factor genes, Hand1 and Mash2 (163), and the expression of these 
genes overlap in the EPC and the SPT. Mash2 maintains giant cell precursors in 
an undifferentiated state (164), whereas Hand1 promotes differentiation into 
TGCs (165). The compromised SPT layer in Cnr1-/- mice may arise from 
misregulated expression of Hand1 and Mash2. Therefore, we examined the 
expression of these two genes at the implantation site on day 10 by in situ 
hybridization. We observed similar Hand1 expression patterns and signal 
intensity in both TGC and SPT cells in WT and Cnr1-/- mice (Figure 16c). 
However, the population of Mash2 positive cells was reduced in Cnr1-/- placentas. 
These results offer two hypotheses: first, the deficiency of Cnr1 in the EPC 
suppresses the proliferation of spongiotrophoblast cells, and thus reduces the 
population of Tpbpa positive trophoblast cells, or the lack of CNR1 in trophoblast 
precursor cells promotes their differentiation to TGC but not SPT cells. 
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Trophoblast cell proliferation is stifled in Cnr1-/- EPC 
To test the hypothesis that CNR1 deficiency inhibits trophoblast cell proliferation 
in the EPC, cell proliferation was examined by BrdU incorporation at the 
implantation sites on day 9 in Cnr1-/- and WT mice. SPT cells are derived from 
t r o p h o b l a s t  c e l l s  i n  t h e  E P C 
 
 
FIGURE 17. Compromised proliferation of trophoblast cells missing Cnr1. 
(a) BrdU incorporation results show that Cnr1-/- TS cells in the EPC proliferate at 
a much slower rate compared to WT TS cells. EPC, ectoplacental cone; Em, 
embryo. Scale bar: 200μm. (b) RT-PCR analysis coupled with Southern blotting 
shows that Cnr1, but not Cnr2, is expressed in WT TS cells. RNA samples from 
brain (Br) and spleen (Sp) were used as positive controls for Cnr1 and Cnr2, 
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respectively. TS, trophoblast stem cells. (c) Proliferation of Cnr1-/-/Cnr2-/- TS cells 
is much slower than WT TS cells in vitro (n=3). (d) Treatment with mAEA 
increases WT TS cell proliferation in vitro, and this effect is suppressed by a 
CNR1 specific inhibitor, SR1 (n=3; unpaired t-test, *P<0.05). 
 
(166), which show rapid proliferation on day 9 of pregnancy. In WT mice, 
increased proliferation was observed in the EPC (Figure 17a), TGC and 
mesometrial decidual cells.  However, the number of BrdU positive cells was 
considerably reduced in Cnr1-/- EPC and TGC. Although many Cnr1-/- embryos 
showed retarded development (Figure 17a, right panel), some Cnr1-/- embryos 
showing development comparable to WT embryos (Figure 17a, middle panel) 
also had fewer BrdU positive cells in EPC and TGC. Similar results were 
observed in Cnr1-/- day 11 implantation sites (Figure 18). Reduced proliferation of 
Cnr1-/- TS (Figure 17a), which later differentiate into SPT, may have resulted in 
compromised SPT development. 
 
 To complement our observations in vivo, proliferation of TS cells were 
assessed in vitro by MTS proliferation assays, in which the cell number is 
reflected by the absorbance of colored product in the presence of a substrate 
(167). Because Cnr2 is not expressed in TS cells (Figure 17b), TS cells deficient 
in both Cnr1 and Cnr2 were used to substitute for Cnr1-/- TS cells in in vitro 
experiments. Standard curves for Cnr1-/-Cnr2-/- and WT TS cells were generated 
from the absorbance values against known numbers of WT and Cnr1-/-/Cnr2-/- TS 
cells. To assess cell proliferation, the same numbers of Cnr1-/-/Cnr2-/- and WT TS 
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cells were seeded in multiple wells, and cell numbers were counted using 
standard curves on given time points shown in Figure 17c. Cnr1-/-Cnr2-/- TS cell 
proliferation was remarkably slower than WT TS cells. To confirm that the effect 
is mediated by CNR1, we further tested WT TS cell proliferation in the presence  
 
Figure 18.  Proliferation of Cnr1-/- trophoblast cells is compromised. In day 
11 (D11) implantation sites, the number of BrdU positive cells in Cnr1-/- EPCs is 
much less than in WT EPC. Results are representative of at least 2 to 3 
independent samples. 
 
of methanandamide (mAEA), a stable analog of AEA, or a vehicle (control). 
Compared to the control group, mAEA-treated WT TS cells proliferated at a 
significantly faster rate (Figure 17d), but were inhibited by SR141716 (SR1), a 
CNR1 selective antagonist, suggesting AEA promotes TS proliferation via CNR1.  
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  SPT cell proliferation is tightly regulated by the PI3K-pAKT signaling 
pathway (168). In addition, cannabinoid signaling via CNR1 can regulate AKT 
activation by the Gi/o/PI3K pathway (169, 170). We speculated that  
 
FIGURE 19. pAKT is localized in TS cells undergoing division. 
Immunofluorescence results show that pAKT is localized in TS cells in the M 
phase of the cell cycle (white arrowheads). TS cells were cultured in TS cell 
media as described in methods. Results are representative of 2 to 3 independent 
samples. Scale bar: 50μm.  
 
endocannabinoid signaling via CNR1 would regulate trophoblast cell proliferation 
by altering AKT activation. Our immunofluorescence results show that pAKT is 
localized in TS cells undergoing division (Figure 19), suggesting pAKT plays a 
role in TS cell proliferation. To test whether CNR1-mediated signaling involves 
AKT signaling in placentation, pAKT was localized by immunohistochemistry in 
day 10 placentas. Most trophoblast cells in the WT EPC were positive for pAKT, 
whereas only sporadic trophoblast cells in the Cnr1-/- EPC were pAKT positive 
(Figure 20a). These results provide evidence that CNR1 deficiency suppresses 
AKT activation, thus downregulating trophoblast cell proliferation in the EPC and 
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SPT. To see whether AKT activation is mediated by the PI3K pathway, WT and 
Cnr1-/-/Cnr2-/- TS cells were treated with  PI3K inhibitor LY294002 and pAKT 
levels were examined by Western blotting (Figure 20b). LY294002 was effective 
in attenuating PI3K activity in WT and Cnr1-/-/Cnr2-/- TS cells. Because CNR1 
deficiency confers compromised TS cell proliferation both in vivo and in vitro 
(Figure 20a and 20c), we speculated that the blockage of PI3K in WT TS cells 
should mimic the effect seen in CNR1 deficiency. Indeed, addition of LY294002 
significantly slowed down proliferation of WT and Cnr1-/-/Cnr2-/- TS cells in a 
concentration dependent manner (Figure 20c). Collectively, the results show that 
CNR1 mediated signaling via the PI3K-AKT pathway is critical for appropriate TS 
cell proliferation.  
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FIGURE 20. Endocannabinoid signaling regulates TS cell proliferation via 
PI3K/AKT signaling. (a) Cnr1-/- placentas have less pAKT positive cells in the 
EPC as indicated by pAKT immunostaining. EPC, ectoplacental cone. Dec, 
decidua basalis. CP, chorionic plate. Results are representative of at least 2 to 3 
independent samples. Scale bar: 200μm. (b) Levels of pAKT in TS cells were 
reduced by PI3K inhibitor LY294002. WT TS cells have higher pAKT levels 
compared to Cnr1-/-/Cnr2-/- TS cells. Total AKT served as a loading control. (c) 
LY294002 attenuated TS cell proliferation in a concentration dependent manner. 
TS cells of both phenotypes were treated with 0, 2, 20, 40μM LY294002 for 72 
hours (n=3). 
 
CNR1 deficient TS cells are biased to differentiate into trophoblast giant 
cells 
Since the SPT in the Cnr1-/- placenta is compromised, we examined whether the 
TS cell fate is biased in the absence of CNR1 in addition to its role in cell 
proliferation. Cnr1-/-/Cnr2-/- TS cells cultured in the presence of FGF4 and mouse 
embryonic fibroblast (MEF) condition medium displayed dramatic morphological 
changes. Cnr1-/-/Cnr2-/- TS cells were of irregular shape, bigger with large nuclei, 
and had numerous stress fibers (Figure 21a). Cytoskeleton reorganization and 
larger cell size indicate that TS cells are prone to differentiate into TGC (171). 
Cnr1-/-/Cnr2-/- TS cells resemble those in a differentiated state, forming loose and 
chaotic cell colonies (Figure 21a). Furthermore, spontaneous differentiation was 
induced in WT and Cnr1-/-/Cnr2-/- TS cells by culturing them in the absence of 
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FGF4 and MEF condition medium. The trophoblast giant cell and spongy cell 
markers were examined by Northern blotting. As shown in figure 21b, although 
WT and Cnr1-/-/Cnr2-/- TS cells differentiate into trophoblast giant cells, as evident 
by the expression of Pl1 gene, the SPT marker Tpbp was only observed in WT 
trophoblast cells. These results indicate that endocannabinoid 
 
FIGURE 21. Cnr1-/- TS cells are more prone to differentiate into TGC. (a) 
Under similar culture conditions, Cnr1-/-/Cnr2-/- TS cells have more stress fibers, 
as evident from increased f-actin immunofluorescence staining. Results are 
representative of at least 2 to 3 independent samples. Scale bar: 50μm. (b) 
Northern blotting results from spontaneous differentiation experiments show that 
WT TS cells expressed both Pl1 and Tpbpa, whereas Cnr1-/-/Cnr2-/- TS cells 
expressed only Pl1, suggesting that most Cnr1-/-/Cnr2-/-TS cells had differentiated 
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into TGCs. Levels of Tpbpa and Pl1 mRNAs were normalized and quantified 
against Rpl7 using the same membrane. 
 
signaling is required to maintain the appropriate TS cell state; the absence of 
CNR1 signaling suppresses differentiation of TS cells into SPT cells, but 
promotes differentiation to TGC.  
 
Cnr1 deficient trophoblast cells show shallow invasion 
The maternal and fetal vascular systems are brought into close proximity through 
placentation, and trophoblast cells directly tap into the maternal vascular system 
(172). Thus, trophoblast cell invasiveness is critical for successful placentation. 
Cyclooxygenase-2 (COX2) is expressed in invading trophoblast cells with the 
initiation of placentation. Immunolocalization shows that Cnr1-/- EPC has reduced 
COX2 expression compared to WT EPC on day 10 of pregnancy (Figure 22b), 
suggesting that Cnr1-/- EPC cells are less invasive. Western blotting results are 
consistent with immunohistochemistry signals (Figure 22c). The invasion of 
glycogen trophoblast cells (GTC) into the decidua basalis is another indicator of 
trophoblast invasiveness. These cells, derived from the SPT on day 12, continue 
to express caudal type homeobox 2 (CDX2) (144). We examined CDX2 
expression in the placenta on day 14. In WT females, an abundant number of 
CDX2-positive glycogen trophoblast cells invade into the decidual basalis, while 
only a sporadic number with shallow invasion were found beyond the TGC 
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border in Cnr1-/- mice (Figure 22a). The results suggest that the trophoblast 
invasive ability is compromised in the absence of CNR1.   
 
 
FIGURE 22. Cnr1-/- trophoblast cells are less invasive. (a) Glycogen 
trophoblast cell invasion into the decidua basalis on day 14 of pregnancy in Cnr1-
/- mice is shallow as shown by CDX2 immunostaining. Scale bar: 100μm. (b) In 
Cnr1-/- mice, the number of COX2- positive cells, invading into the maternal 
decidua around the ectoplacental cone, is low. Scale bar: 200μm. (c) Western 
blotting of COX2 levels in extracts of isolated EPC from day 10 WT and Cnr1-/- 
implantation sites. (d) In in vitro invasion assays, numbers of Cnr1-/-/Cnr2-/- TS 
cells successfully penetrating through the matrigel are much lower than those of 
WT TS cells.  Invasive capacity of WT TS cells is attenuated by a CNR1 
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antagonist SR1 (7nM), indicating that CNR1 is critical for normal TS cell invasion. 
Results are representative of at least 2 to 3 independent samples. 
 
Matrigel invasion assays were used to study the invasive ability of TGC (173). 
Using this assay, we examined the effects of endocannabinoid signaling on TS 
cell invasive behavior in vitro. Only a limited number of Cnr1-/-/Cnr2-/- TS cells 
were able to penetrate through the matrigel membrane after 44 hrs in culture 
(Figure 22d), suggesting that CNR1 deficiency suppresses the invasive ability of 
trophoblast cells. In addition, WT TS cell invasiveness was blocked by the CNR1-
selective antagonist SR1, but not SR144528 (SR2), a CNR2 antagonist. The 
results show that the silencing of CNR1 dampens trophoblast invasion. 
 
Discussion 
To support fetal survival and growth, a functional placenta requires an 
appropriate and balanced amount of different trophoblast cells. Using the CNR1 
deficient mouse, we show that endocannabinoid signaling, which presents in the 
EPC and thereafter in the spongiotrophoblast layer, plays roles in both 
trophoblast cell growth and differentiation. The ablation of CNR1-mediated 
endocannabinoid signaling inhibits TS cell proliferation, differentiation into SPT 
cells, and trophoblast invasiveness. Consequently, defective placentation and 
fetal development lead to increased rates of resorption in Cnr1-/- mice.  
 
The spongy layer is located between the outer secondary TGCs and inner 
labyrinth layer. The function of the spongiotrophoblast layer is still not clearly 
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understood. It is thought to function as structural support for the developing 
labyrinth which is populated by maternal and fetal capillaries (172). Studies in 
Mash2 deficient mice have revealed that all of the labyrinth, SPT and TGC layers 
are affected in the absence of Mash2 (174), even though Mash2 is specifically 
expressed within the spongy layer. This indicates that a well-developed 
spongiotrophoblast layer is required for normal placentation. We found that 
CNR1 is expressed in the EPC and later in SPT layers. The CNR1 deficient 
placenta has a reduced Tpbp-positive SPT layer with unaffected TGCs. Thus, the 
compromised SPT development leads to abnormal placentation and 
consequently resorption of the feto-placental unit.  
 
The expression of Hand1 and Mash2 overlaps in the ectoplacental cone and 
spongiotrophoblast layer in which Tpbpa-positive trophoblast precursor cells 
reside. The coordinated antagonistic effects of Hand1 and Mash2 regulate the 
differentiation of the precursor cells into secondary TGCs (163). However, a 
recent cell lineage tracing study shows that not all secondary TGCs are derived 
from Tpbpa positive cells, indicating that the cell fate of some TGCs is decided 
before Tpbpa expression (175). In vitro spontaneous differentiation experiments 
with Cnr1-/-/Cnr2-/- TS cells show that Tpbpa is barely detected, indicating that 
most, if not all, TS cells differentiate into TGC cells in the absence of CNR1. It is 
possible that deficiency of CNR1 directly promotes differentiation of TS cells into 
TGCs in vitro, without going through the transition phase of Tpbpa positive 
precursor cells.  Alternatively, the reduced Tpbpa-positive cells in Cnr1-/- mice 
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could be the consequence of reduced TS cell proliferation. To dissect out the role 
of CNR1 in TS cell proliferation from its role in TS cell differentiation, cell 
proliferation was examined using FGF4 and MEF-condition medium to keep the 
TS cells undifferentiated. We found that TS cell division is coupled with 
upregulated pAKT, and deficiency of CNR1 dampens TS cell proliferation by 
downregulating pAKT levels. These results are consistent with previous studies 
in other systems where CNR1 is coupled with Gi/o and activates AKT signaling 
by turning on 1-Phosphatidylinositol 3-Kinase (169, 170, 176). 
 
In the MTS cell proliferation assay used to examine TS cell proliferation, the 
basic principle is that the mitochondria reductase in viable cells can turn 
phenazine methosulfate (PMS) and MTS into water-soluble formazan, giving a 
purple color. The absorbance (maximum at 490-500 nm) of this colored solution 
proportionally reflects the number of viable cells (167). Two standard curves 
were generated using the given number of WT or Cnr1-/-/Cnr2-/- TS cells. Both 
curves were linear, validating that the colorimetric readings are proportional to 
cell numbers. Intriguingly, the slope of the curve for Cnr1-/-/Cnr2-/- TS cells is 
greater than that of the WT TS cells, indicating Cnr1-/-/Cnr2-/- TS cells have more 
mitochondria reductase than WT TS cells. These results demonstrate that Cnr1-/-
/Cnr2-/- TS cells are more metabolically active than WT TS cells.   
 
Endocannabinoid signaling has been shown to be present in human and rat 
placentas (158, 177). The conserved presence of the endocannabinoid system in 
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placenta indicates its role in placentation. However, it was not clear how 
endocannabinoid signaling regulates placentation. Using the mouse model, we 
show here that endocannabinoid signaling is capable of interfering with the fate 
of mouse TS cell differentiation, and that aberrant endocannabinoid signaling 
causes defective placental development and higher incidence of fetal resorptions 
in midgestation. Our studies on endocannabinoid signaling in the mouse placenta 
may shed some light on potential endocannabinoid studies in humans. 
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CHAPTER IV 
 
CLOSING REMARKS 
 
More and more lipid molecules are being revealed as indispensable components 
of different biological signaling pathways. Some of these lipid mediators are 
found to be critical in coordinating events of early pregnancy. Our laboratory has 
demonstrated that appropriate endocannabinoid signaling is critical to 
preimplantation embryo development, their timely homing into the receptive 
uterus and on-time implantation (10-12). My work has added new dimensions to 
the role of endocannabinoid signaling by extending its role in sperm function in 
the context of fertilization in male reproduction and placentation in female 
reproduction. 
 
In males, the components of the endocannabinoid system are found in the testis 
and epididymis. To study the effect of marijuana in reproductive functions in 
chronic marijuana users, I have characterized male reproductive phenotypes in 
mice with genetic loss of Faah. In these mice, the levels of anandamide in the 
testis and epididymis are elevated, mimicking long-term exposure to marijuana. 
The aberrant endocannabinoid signaling compromises the fertilizing capacity of 
sperm. Retention of Faah-/- sperm on the egg zona-pellucida provides evidence 
that sperm’s capacity to penetrate the zona barrier is dampened. Furthermore, 
we showed this defect is rescued by superimposing deletion of CNR1, indicating 
 81
the endocannabinoid signaling on sperm is mediated by CNR1. Men who smoke 
marijuana frequently have significantly less seminal fluid, a lower total sperm 
count and their sperm behave abnormally, all of which may affect fertility 
adversely. My studies may provide therapeutic targets to improve male fertility.  
 
In females, our lab’s previous studies demonstrated the roles of endocannabinoid 
signaling in preimplantation embryo development and oviductal transportation. 
My work expands our understanding to midgestation in pregnancy. Previous 
studies in our lab showed the endocannabinoid system was present in embryos, 
and my work revealed that the expression of CNR1 and FAAH is retained in 
trophoblast stem cells and spongy cells during placentation. In addition, the 
endocannabinoids are also actively synthesized in placenta. Using mice deficient 
of CNR1, we showed endocannabinoid signaling via CNR1 is required for TS 
cells to appropriately differentiate into spongiotrophoblast and trophoblast giant 
cells. CNR1 deficient TS cells are biased to differentiate into trophoblast giant 
cells. In addition, CNR1 mediated endocannabinoid signaling via the PI3K-AKT 
pathway also regulates TS cell proliferation. 
 
Genetically manipulated mouse models studied to date are not totally infertile, 
indicating the role of endocannabinoid signaling is complimentary to fertility 
regulation. However, my work, together with previous studies, demonstrates 
endocannabinoid signaling has various roles in different physiological processes 
in both male and female reproduction. The fact that it is present in different 
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animal species further proves that evolutionarily conserved lipid signaling is 
important for reproduction. Further studies are needed to reveal additional 
functions of endocannabinoid signaling in reproduction and other physiological 
processes. 
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